WO2023033457A1 - Snp marker for predicting high water temperature tolerance of flatfish, and use thereof - Google Patents
Snp marker for predicting high water temperature tolerance of flatfish, and use thereof Download PDFInfo
- Publication number
- WO2023033457A1 WO2023033457A1 PCT/KR2022/012747 KR2022012747W WO2023033457A1 WO 2023033457 A1 WO2023033457 A1 WO 2023033457A1 KR 2022012747 W KR2022012747 W KR 2022012747W WO 2023033457 A1 WO2023033457 A1 WO 2023033457A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- base
- polynucleotide consisting
- seq
- polynucleotide
- nucleotide sequence
- Prior art date
Links
- 239000003550 marker Substances 0.000 title claims abstract description 38
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title abstract description 23
- 241000269978 Pleuronectiformes Species 0.000 title abstract description 15
- 238000000034 method Methods 0.000 claims abstract description 24
- 108091033319 polynucleotide Proteins 0.000 claims description 786
- 102000040430 polynucleotide Human genes 0.000 claims description 786
- 239000002157 polynucleotide Substances 0.000 claims description 786
- 239000002773 nucleotide Substances 0.000 claims description 374
- 125000003729 nucleotide group Chemical group 0.000 claims description 374
- 230000000295 complement effect Effects 0.000 claims description 217
- 241000269908 Platichthys flesus Species 0.000 claims description 39
- 241000269980 Pleuronectidae Species 0.000 claims description 26
- 239000000523 sample Substances 0.000 claims description 15
- 239000003795 chemical substances by application Substances 0.000 claims description 13
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 12
- 238000002360 preparation method Methods 0.000 claims description 2
- 238000010924 continuous production Methods 0.000 abstract description 2
- 238000011161 development Methods 0.000 abstract description 2
- 238000012248 genetic selection Methods 0.000 abstract description 2
- 230000004083 survival effect Effects 0.000 description 63
- 238000004458 analytical method Methods 0.000 description 22
- 238000011144 upstream manufacturing Methods 0.000 description 20
- 108700028369 Alleles Proteins 0.000 description 14
- 210000000349 chromosome Anatomy 0.000 description 13
- 108020004414 DNA Proteins 0.000 description 12
- 230000034994 death Effects 0.000 description 9
- 241000251468 Actinopterygii Species 0.000 description 8
- 230000002068 genetic effect Effects 0.000 description 6
- 238000003908 quality control method Methods 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 5
- 238000009396 hybridization Methods 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 238000012163 sequencing technique Methods 0.000 description 5
- 102000005604 Myosin Heavy Chains Human genes 0.000 description 4
- 108010084498 Myosin Heavy Chains Proteins 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 230000001186 cumulative effect Effects 0.000 description 4
- 238000002493 microarray Methods 0.000 description 4
- 238000000018 DNA microarray Methods 0.000 description 3
- 101000979565 Homo sapiens Protein NLRC5 Proteins 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 108091092878 Microsatellite Proteins 0.000 description 3
- 102100023432 Protein NLRC5 Human genes 0.000 description 3
- 230000003321 amplification Effects 0.000 description 3
- 238000012937 correction Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000003199 nucleic acid amplification method Methods 0.000 description 3
- 150000007523 nucleic acids Chemical group 0.000 description 3
- -1 nucleoside triphosphates Chemical class 0.000 description 3
- 239000013535 sea water Substances 0.000 description 3
- 201000009187 Bardet-Biedl syndrome 2 Diseases 0.000 description 2
- 102100027883 Bardet-Biedl syndrome 2 protein Human genes 0.000 description 2
- 101000697700 Homo sapiens Bardet-Biedl syndrome 2 protein Proteins 0.000 description 2
- 101001037204 Homo sapiens Hydrocephalus-inducing protein homolog Proteins 0.000 description 2
- 102100040204 Hydrocephalus-inducing protein homolog Human genes 0.000 description 2
- 102100034343 Integrase Human genes 0.000 description 2
- 101100340155 Mus musculus Hydin gene Proteins 0.000 description 2
- 102100037704 N-terminal EF-hand calcium-binding protein 2 Human genes 0.000 description 2
- 101710144100 N-terminal EF-hand calcium-binding protein 2 Proteins 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 2
- 101150050367 Sf3b3 gene Proteins 0.000 description 2
- 102100021816 Splicing factor 3B subunit 3 Human genes 0.000 description 2
- 101710190370 Splicing factor 3B subunit 3 Proteins 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000007834 ligase chain reaction Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 239000002777 nucleoside Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 239000001226 triphosphate Substances 0.000 description 2
- 235000011178 triphosphate Nutrition 0.000 description 2
- 102000006268 Alanine-tRNA ligase Human genes 0.000 description 1
- 108010058060 Alanine-tRNA ligase Proteins 0.000 description 1
- QCMYYKRYFNMIEC-UHFFFAOYSA-N COP(O)=O Chemical class COP(O)=O QCMYYKRYFNMIEC-UHFFFAOYSA-N 0.000 description 1
- 102100035244 Cerebellin-1 Human genes 0.000 description 1
- 108020004635 Complementary DNA Proteins 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
- 102100021838 E3 ubiquitin-protein ligase SIAH1 Human genes 0.000 description 1
- 101710128187 E3 ubiquitin-protein ligase Siah1 Proteins 0.000 description 1
- 101150045738 EXOSC6 gene Proteins 0.000 description 1
- 102100026063 Exosome complex component MTR3 Human genes 0.000 description 1
- 101710141178 Exosome complex component MTR3 Proteins 0.000 description 1
- 102000034354 Gi proteins Human genes 0.000 description 1
- 108091006101 Gi proteins Proteins 0.000 description 1
- 102100029003 Glucose-fructose oxidoreductase domain-containing protein 1 Human genes 0.000 description 1
- 101710162036 Glucose-fructose oxidoreductase domain-containing protein 1 Proteins 0.000 description 1
- 102100025296 Guanine nucleotide-binding protein G(o) subunit alpha Human genes 0.000 description 1
- 101710191917 Guanine nucleotide-binding protein G(o) subunit alpha Proteins 0.000 description 1
- 101000737277 Homo sapiens Cerebellin-1 Proteins 0.000 description 1
- 101000650674 Homo sapiens N-lysine methyltransferase SETD6 Proteins 0.000 description 1
- 101001135199 Homo sapiens Partitioning defective 3 homolog Proteins 0.000 description 1
- 102100034028 Membrane-bound transcription factor site-1 protease Human genes 0.000 description 1
- 102100027709 N-lysine methyltransferase SETD6 Human genes 0.000 description 1
- 101150054011 N4bp1 gene Proteins 0.000 description 1
- 102100038552 NEDD4-binding protein 1 Human genes 0.000 description 1
- 101710081124 NEDD4-binding protein 1 Proteins 0.000 description 1
- 102100033496 Partitioning defective 3 homolog Human genes 0.000 description 1
- 102100023856 Ran-binding protein 10 Human genes 0.000 description 1
- 101710161670 Ran-binding protein 10 Proteins 0.000 description 1
- 102100027663 Rho GTPase-activating protein 12 Human genes 0.000 description 1
- 101710110386 Rho GTPase-activating protein 12 Proteins 0.000 description 1
- 102100037356 SLIT-ROBO Rho GTPase-activating protein 1 Human genes 0.000 description 1
- 101710104382 SLIT-ROBO Rho GTPase-activating protein 1 Proteins 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 102100028474 Serine/threonine-protein kinase H1 Human genes 0.000 description 1
- 101710125214 Serine/threonine-protein kinase H1 Proteins 0.000 description 1
- 108020004682 Single-Stranded DNA Proteins 0.000 description 1
- 108091027568 Single-stranded nucleotide Proteins 0.000 description 1
- RYYWUUFWQRZTIU-UHFFFAOYSA-N Thiophosphoric acid Chemical class OP(O)(S)=O RYYWUUFWQRZTIU-UHFFFAOYSA-N 0.000 description 1
- 102100036215 Translin-associated factor X-interacting protein 1 Human genes 0.000 description 1
- 101710134195 Translin-associated factor X-interacting protein 1 Proteins 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 101100467537 Xenopus tropicalis ranbp9 gene Proteins 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000007844 allele-specific PCR Methods 0.000 description 1
- 150000001413 amino acids Chemical group 0.000 description 1
- 238000004450 analytical method by type Methods 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 238000009360 aquaculture Methods 0.000 description 1
- 244000144974 aquaculture Species 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 238000012098 association analyses Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 150000004657 carbamic acid derivatives Chemical class 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000010219 correlation analysis Methods 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- NAGJZTKCGNOGPW-UHFFFAOYSA-N dithiophosphoric acid Chemical class OP(O)(S)=S NAGJZTKCGNOGPW-UHFFFAOYSA-N 0.000 description 1
- 238000009313 farming Methods 0.000 description 1
- 230000004720 fertilization Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000012252 genetic analysis Methods 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000002008 hemorrhagic effect Effects 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- MRWXACSTFXYYMV-FDDDBJFASA-N nebularine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC=C2N=C1 MRWXACSTFXYYMV-FDDDBJFASA-N 0.000 description 1
- PTMHPRAIXMAOOB-UHFFFAOYSA-N phosphoramidic acid Chemical class NP(O)(O)=O PTMHPRAIXMAOOB-UHFFFAOYSA-N 0.000 description 1
- 150000008300 phosphoramidites Chemical class 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 230000000379 polymerizing effect Effects 0.000 description 1
- 102000054765 polymorphisms of proteins Human genes 0.000 description 1
- 239000002212 purine nucleoside Substances 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 238000012253 re-sequencing analysis Methods 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000007894 restriction fragment length polymorphism technique Methods 0.000 description 1
- 238000009394 selective breeding Methods 0.000 description 1
- 101150041654 setd6 gene Proteins 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 108010048078 site 1 membrane-bound transcription factor peptidase Proteins 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 108091005703 transmembrane proteins Proteins 0.000 description 1
- 102000035160 transmembrane proteins Human genes 0.000 description 1
- 238000009966 trimming Methods 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
Definitions
- the present disclosure relates to a SNP marker composition for predicting High Water Temperature Tolerance (HWTT) of flounder and a method for predicting high temperature tolerance of flounder using the same.
- HWTT High Water Temperature Tolerance
- seawater temperature is an important variable in aquaculture production in onland farms or cage farms using natural seawater. It is known that it can cause various problems. Therefore, a new breed that can withstand the high temperature period is needed, and in order to develop the breed, genetic selective breeding based on a method for selecting high temperature resistant halibut is required.
- An object of the present disclosure is to provide a SNP marker composition for predicting high temperature resistance of flounder, a composition comprising an agent capable of detecting or amplifying it, a kit for predicting high temperature resistance of flounder including the composition, and a method for predicting high temperature resistance of flounder will be.
- the present disclosure provides that the 36th base of the polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 1 is G or A, and the polynucleotide consisting of 10 to 100 consecutive bases including the 36th base.
- a polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 4 wherein the 36
- the present disclosure is a composition for predicting high temperature resistance of flounder, including an agent capable of detecting or amplifying a SNP marker for predicting high temperature resistance of flounder, wherein the SNP marker is a polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 1
- the 36th base of is G or A, and a polynucleotide consisting of 10 to 100 consecutive bases including the 36th base or a polynucleotide complementary thereto;
- the agent may be a primer or probe capable of detecting or amplifying the SNP marker.
- the present disclosure provides a kit for predicting high-temperature resistance of flatfish, including the composition for predicting high-temperature resistance of flounder.
- the present disclosure provides (a) amplifying or detecting a polymorphic site of a SNP marker for predicting high temperature resistance of flounder from DNA of a sample isolated from flounder; and (b) determining the base of the polymorphic site amplified or detected in step (a), wherein the SNP marker in step (a) is 36 nucleotides of the polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 1.
- the present disclosure is a kit for predicting high temperature tolerance of halibut; And in a method for predicting high-temperature tolerance of flatfish, it provides the use of the above-described SNP marker composition for predicting high-temperature tolerance of flatfish.
- the SNP marker composition of the present disclosure can be used for genetic selection of halibut with high temperature tolerance.
- Figure 1 is a graph showing the cumulative mortality according to the water temperature change in the high temperature tolerance experiment.
- Figure 2 shows the GWAS analysis by type (survival status, survival days, survival time) for high temperature tolerance.
- 3 to 32 show the phenotypic distribution of genotypes of 30 SNPs for prediction of high temperature tolerance.
- the present disclosure is a single nucleotide polymorphism that can predict high-temperature tolerance through genotypic analysis and genome-wide association study (GWAS) using a 70K SNP chip for halibut for individuals selected from high-temperature exposure experiments ( SNP) was confirmed.
- GWAS genotypic analysis and genome-wide association study
- the present disclosure relates to a SNP marker composition for predicting high temperature tolerance of halibut.
- the present disclosure discloses that the 36th base of a polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 1 is G or A, and a polynucleotide consisting of 10 to 100 consecutive bases including the 36th base or a polynucleotide complementary thereto polynucleotide;
- a polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 2 wherein the 36th base is A or G, and a polynucleotide consisting of 10 to 100 consecutive bases including the 36th base, or a polynucleotide complementary thereto
- high water temperature resistance refers to the property of enduring an increase in water temperature, and specifically, when a high water temperature of 29.0 ° C to a maximum of 33.7 ° C is maintained, resistance to growth slowdown or disease occurrence due to water temperature shock, weakening of immunity, decline in physiological function, etc. means to have
- SNP marker in the present disclosure refers to a single base polymorphic allele base pair on a DNA sequence used to identify an individual or species. Since SNPs have a relatively high frequency, are stable, and are distributed throughout the genome, resulting in genetic diversity of individuals, SNP markers can serve as indicators of genetic proximity between individuals. SNP markers usually include phenotypic changes accompanying single nucleotide polymorphisms, but may not in some cases. In the case of the SNP marker of the present disclosure, it may represent a difference in phenotype of an individual such as amino acid sequence variation or high temperature tolerance of halibut.
- the term "individual” of the present disclosure means a halibut (flatfish), which is a target for confirming high-temperature resistance, and by analyzing the genotype of the SNP marker using a sample obtained from the flounder (flatfish), the high-temperature resistant flatfish (flatfish) can be identified.
- a 70K SNP chip prepared after searching for SNPs in the mother genome by whole genome re-sequencing of the flounder mother generation was used.
- the search was conducted by narrowing the scope to SNPs associated with high temperature tolerance.
- effective SNPs highly related to high temperature tolerance were found on chromosomes 18 and 19.
- the phenotypic distribution of the genotypes of the SNPs was analyzed to determine 30 SNP information, and the reliability and accuracy of the SNP markers of the present disclosure were confirmed to confirm that high-temperature tolerance of flounder could be predicted.
- a polynucleotide consisting of 10 to 100 contiguous bases comprising the nucleotide sequence of SEQ ID NO: 1 of the present disclosure or a polynucleotide complementary thereto to 10 to 100 contiguous bases comprising the nucleotide sequence of SEQ ID NO: 30 It suggests that halibut containing at least one selected from the group consisting of a polynucleotide consisting of or a polynucleotide complementary thereto may exhibit high-temperature resistance traits, and such a base sequence was identified for the first time by the present inventors.
- the present disclosure provides a composition for predicting high-temperature tolerance of flounder, including an agent capable of detecting or amplifying a SNP marker for predicting high-temperature resistance of flounder.
- agent capable of detecting or amplifying a SNP marker refers to a composition capable of predicting high-temperature resistant flounder by confirming the polymorphic region of the gene as described above through detection or amplification, preferably the SNP A primer set or probe capable of specifically detecting or amplifying a polynucleotide of a marker.
- the primers used to amplify the SNP markers are prepared in the form of template-directed DNA under suitable conditions (eg, four different nucleoside triphosphates and a polymerizing agent such as DNA, RNA polymerase or reverse transcriptase) in an appropriate buffer and at an appropriate temperature. It can be a single-stranded oligopolynucleotide that can serve as a starting point for synthesis.
- the appropriate length of the primer may vary depending on the purpose of use, but is usually 15 to 30 polynucleotides. Short primer molecules generally require lower temperatures to form stable hybrids with the template.
- the primer sequence need not be perfectly complementary to the SNP marker, but must be sufficiently complementary to hybridize with the SNP marker.
- primer in the present disclosure is a base sequence having a short free 3' terminal hydroxyl group, capable of forming a base pair with a complementary template, and starting for copying the template strand. It refers to a short sequence that functions as a point, and is mainly used in the form of a primer set that amplifies a specific section.
- a primer can initiate DNA synthesis in the presence of a reagent for polymerization (i.e., DNA polymerase or reverse transcriptase) and four different nucleoside triphosphates in an appropriate buffer and temperature. At this time, PCR conditions and lengths of sense and antisense primers may be modified based on those known in the art.
- the term "probe” is DNA or RNA nucleotide sequences of various lengths labeled with radioactive or fluorescent labels, and is composed of single-stranded nucleotide sequences and is specific for single-stranded DNA or RNA having complementary sequences. It is characterized in that it binds and hybridizes with the target, and the target can be detected through a method of detecting the label signal of the hybridized probe.
- the primers or probes of this disclosure can be chemically synthesized using the phosphoramidite solid support method, or other well-known methods.
- Such nucleic acid sequences can also be modified using a number of means known in the art. Non-limiting examples of such modifications include methylation, capping, substitution of one or more homologs of a natural nucleotide, and modifications between nucleotides, such as uncharged linkages such as methyl phosphonates, phosphotriesters, phosphoro amidates, carbamates, etc.) or to charged linkages (eg phosphorothioates, phosphorodithioates, etc.).
- the present disclosure provides a kit for predicting high temperature resistance of flounder, including the composition for predicting high temperature resistance of flounder.
- the kit of the present disclosure may be a DNA chip kit, but is not limited thereto.
- the DNA chip kit uses a chip attached with a polynucleotide sequence containing a SNP marker, which is a marker for predicting high temperature resistance of flounder, or an oligopolynucleotide containing a complementary nucleotide sequence thereof, to specifically hybridize and bind to target DNA Characterized in that, it is possible to predict high-temperature tolerant halibut using the change in hybridization level according to the base variation of the SNP.
- a SNP marker which is a marker for predicting high temperature resistance of flounder
- an oligopolynucleotide containing a complementary nucleotide sequence thereof to specifically hybridize and bind to target DNA Characterized in that, it is possible to predict high-temperature tolerant halibut using the change in hybridization level according to the base variation of the SNP.
- the DNA chip kit for predicting high temperature resistance of flounder is selected from the group consisting of a polynucleotide comprising the nucleotide sequence of SEQ ID NO: 1 to a polynucleotide comprising the nucleotide sequence of SEQ ID NO: 30 At least one polynucleotide or a polynucleotide consisting of 10 to 100 bases including its 36th base and an oligopolynucleotide complementary to a marker are attached to a chip, and target DNA is reacted with the chip to determine the genotype through hybridization. It may be a kit for predicting high temperature tolerance of halibut, which is a kit for determining.
- step (a) amplifying or detecting a polymorphic site of the SNP marker for predicting high temperature resistance of claim 1 from the DNA of a flounder sample; and (b) determining the base of the polymorphic site amplified or detected in step (a).
- any method known to those skilled in the art may be used for amplifying the polynucleotide from the DNA sample in step (a). For example, it can be obtained by amplifying a target nucleic acid through PCR and purifying it. Other techniques such as ligase chain reaction (LCR), transcription amplification, and self-maintained sequence replication and nucleic acid-based sequence amplification (NASBA) may be used.
- LCR ligase chain reaction
- NASBA self-maintained sequence replication and nucleic acid-based sequence amplification
- Step (a) may be amplifying or detecting a base using a primer or a probe.
- the method for determining the base of the amplified SNP marker region in step (b) includes sequencing analysis, microarray hybridization, allele specific PCR, and dynamic allele hybridization technique.
- allele-specific hybridization DASH
- PCR extension analysis PCR-SSCP
- PCR-RFLP analysis HRM analysis or TaqMan techniques
- SNPlex platform Applied Biosystems
- mass spectrometry eg Sequenom's MassARRAY system
- mini-sequencing mini-sequencing
- Bio-Plex systems BioRad
- CEQ and SNPstream systems Beckman
- Molecular Inversion Probe array technology eg, Affymetrix GeneChip
- BeadArray Technologies eg, Illumina GoldenGate and Infinium assays).
- One or more alleles in the SNP marker can be identified by the above methods or other methods available to those skilled in the art.
- Example 1 High-density SNP 70K chip for halibut
- MS loci loci Individuals selected from 1,291 flounder populations prepared based on the allele and correlation analysis results of 11 microsatellite (MS) loci loci were selected based on QC results for genomic DNA, group, mating status, Considering gender, 100 fish were finally selected from the flounder population for whole genome re-sequencing analysis.
- MS microsatellite
- the Axiom TM my Design TM SNP chip (50 to 90K) platform was selected.
- the secured high-quality SNPs are classified into tiers according to their importance, and 154,964 SNPs are classified according to 1) genotype rate for 100 animals, 2) LD block, 3) repeat, and 4) MAF range.
- the population structure of 100 halibut was analyzed based on the selected 155K SNPs, a pattern similar to the results of the analysis with the 11 MS markers used previously was found, indicating that the collected flounder population was different according to the collection area (group). It is assumed that the specificity is strong and genetic fixation within the population is judged to be high.
- 71,364 SNPs were finally determined considering the SNP chip (50 to 90K) platform. have been selected The selected SNPs were evenly distributed across 24 chromosomes, and 70% of the distances between SNPs were within 5,000 bp, and most of them were identified as less than 10,000 bp.
- a 70K SNP chip for halibut in the form of a total of 384 wells/plate was manufactured so that 71,364 SNPs were planted in one chip.
- the flounder used as the experimental fish was a flounder group produced according to the breeding guidelines of Jeju National University from a flounder mother group collected at the Jeju Maritime and Fisheries Research Institute. Specifically, the nF0 generation was mass-produced from 354 sexually mature mother candidates (126 females, 288 males) through natural spawning and natural fertilization, and reared to a size of 20 to 30 cm. 400 animals per tank were stocked in 2 m-sized tanks and allowed to acclimate for 3 days at 19.4°C water temperature. At this time, the water tank used a circulating filter system that can control the water temperature with a boiler. A total of 769 animals were used in the high-temperature exposure experiment by removing objects showing abnormal symptoms during the acclimatization period. Feed was fed twice a day until the water temperature was 30°C, and feeding was stopped after the first death.
- the water temperature was adjusted so that it could rise by about 1 ° C per day from the temperature of the fish to 30 ° C, and it was adjusted so that it could rise by about 0.5 ° C per day to 32.5 ° C, which is known as the critical temperature of halibut.
- Water temperature and dissolved oxygen were measured at regular intervals to ensure that oxygen saturation was maintained at 90% or more.
- the dead individuals were collected at regular intervals from the time of the first death, and the size, weight, and external symptoms were checked, and the tail fins were collected and stored frozen.
- Genomic DNA was extracted from 50 mg of the caudal fin of the experimental fish using the QIAamp 96 DNA QIAcube HT Kit (Qiagen, Germany).
- a microarray was performed on 763 samples that passed gDNA quality control (QC) using a 70K SNP chip designed and manufactured for halibut in Example 1.
- the average total length of 769 experimental fish was 25.42 ⁇ 1.63 cm, the average width was 8.84 ⁇ 0.65 cm, and the average body weight was 159.1 ⁇ 29.9 g.
- the water temperature at which the first death occurred after the temperature increase was 30.7 ° C, and the water temperature was raised and maintained from 30.7 ° C to a maximum of 32.7 ° C for 4 days from the first death.
- the water temperature was lowered from dawn on the 4th day after the first death, and the surviving individuals were classified as survivors.
- the total number of dead fish was 538, which was calculated as a cumulative mortality rate of 69.96%, and the number of surviving fish was confirmed as 231 (Table 2).
- the survival analysis according to high temperature exposure was 1) survival (survival), 2) number of survival days (DPC_Day), which is how many days have elapsed since the first death, and 3) survival time (DPC_Time, which is how many hours have passed since the first death) ), the score was given and applied to the analysis.
- GWAS Genome-Wide Association Study
- the heritability ( h 2 ) according to survival was estimated to be 0.620, and specific SNPs related thereto were identified on chromosomes 18 and 19.
- the heritability according to DPC_Day was estimated to be 0.753, and specific SNPs related thereto were identified on chromosomes 18 and 19, similar to the results of survival GWAS.
- SNPs were selected for prediction of high temperature resistant individuals, and the nucleotide sequence of the selected SNPs and the genes related to each SNP were selected. Information is as shown in Table 6.
- the 30 SNPs were determined as high temperature resistant genotypes based on the following analysis results.
- Table 7 and FIGS. 3 to 32 show information on each SNP associated with high temperature resistance and average and standard deviation of survival days and survival time for each genotype and graphs.
- the number of survival days (DPC_Day) was assigned a value of 1 to 8 as many as the number of survival days for each individual, and the survival time (DPC_Time) was the date of occurrence of the first dead individual after converting the death date of each individual into a serial number using Excel. 1 was performed.
- DPC_Day The number of survival days (DPC_Day) was assigned a value of 1 to 8 as many as the number of survival days for each individual
- the survival time (DPC_Time) was the date of occurrence of the first dead individual after converting the death date of each individual into a serial number using Excel. 1 was performed.
- the survival and genotype of each individual the number of surviving or dead individuals for each genotype was confirmed, and based on this, it was shown in
- G. (215) mean ⁇ standard deviation number of days to live 6.71 ⁇ 2.36 3.85 ⁇ 2.63 2.18 ⁇ 1.84 survival time 10.38 ⁇ 4.42 5.14 ⁇ 4.72 2.60 ⁇ 2.98 14 19 4476416 AX-419310954 C Variation (Number of Populations) CC (139) CT (376) TT (207) mean ⁇ standard deviation number of days to live 6.61 ⁇ 2.42 4.03 ⁇ 2.68 2.05 ⁇ 1.71 survival time 10.18 ⁇ 4.53 5.44 ⁇ 4.83 2.44 ⁇ 2.76 15 19 4230401 AX-419194853 G Variation (Number of Populations) AA (27) AG (334) G. G.
- G. (39) mean ⁇ standard deviation number of days to live 4.97 ⁇ 2.88 3.02 ⁇ 2.46 2.03 ⁇ 1.77 survival time 7.18 ⁇ 5.25 3.91 ⁇ 4.21 2.37 ⁇ 2.83 21 18 11576382 AX-419304244 T Variation (Number of Populations) G. G.
- G. (282) mean ⁇ standard deviation number of days to live 2.68 ⁇ 2.30 3.04 ⁇ 2.45 5.45 ⁇ 2.81 survival time 3.43 ⁇ 3.91 3.92 ⁇ 4.20 8.02 ⁇ 5.19 30 19 4781952 AX-419194922 T Variation (Number of Populations)
- G. G. (334) TG (338) TT (48) mean ⁇ standard deviation number of days to live 2.42 ⁇ 2.03 5.09 ⁇ 2.80 6.42 ⁇ 2.53 survival time 2.94 ⁇ 3.33 7.34 ⁇ 5.20 9.80 ⁇ 4.75
- Table 8 shows the heritability estimated from the GWAS analysis for high temperature tolerance through genetic parameter analysis.
- Heritability associated with high temperature tolerance phenotypic trait heritability Heritability ( h 2 ) P-value Significant to select major related chromosomes Survival 0.620 8.47 x 10 -7 Significant 18 and 19 Days to surviveDPC_Day 0.753 8.47 x 10 -7 Significant 18 and 19 survival timeDPC_Time 0.710 8.47 x 10 -7 Significant 18 and 19
- the single nucleotide polymorphism (SNP) marker composition for predicting high temperature resistance can induce the development and continuous production of high temperature resistant varieties, which can be of great help to flounder farming.
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
구분division | 최소값minimum | 제1사분위수1st quartile | 중간값median | 평균average | 제3사분위수3rd quartile | 최고값highest value |
전장 (cm)Overall length (cm) | 20.020.0 | 24.424.4 | 25.525.5 | 25.42±1.6325.42±1.63 | 26.526.5 | 29.829.8 |
체폭 (cm)body width (cm) | 7.07.0 | 8.48.4 | 8.98.9 | 8.84±0.658.84±0.65 | 9.29.2 | 10.510.5 |
체중 (g)weight (g) | 7878 | 140140 | 158158 | 159.1±29.9159.1±29.9 | 178178 | 244244 |
첫폐사후일수Number of days after first lung death | 수온 변화 범위Water temperature change range | 폐사개체수dead population |
누적 폐사개체수accumulate dead population |
생존개체수number of survivors | 누적폐사율cumulative mortality |
순치(3일) ~수온상승기간(12일)Sunchi (3 days) ~ water temperature rise period (12 days) |
19.4℃ 내지 30.7℃19.4°C to 30.7° |
00 | 00 | 769769 | 0%0% |
D+1D+1 |
30.7℃ 내지 30.9℃30.7°C to 30.9° |
158158 | 158158 | 611611 | 20.55%20.55% |
D+2D+2 | 30.8℃ 내지 32.2℃30.8°C to 32.2°C | 251251 | 409409 | 360360 | 53.19%53.19% |
D+3D+3 | 32.2℃ 내지 32.6℃32.2°C to 32.6°C | 8888 | 497497 | 272272 | 64.63%64.63% |
D+4D+4 |
32.6℃ 내지 31.2℃32.6°C to 31.2° |
3434 | 531531 | 238238 | 69.05%69.05% |
D+5D+5 | 19.7℃19.7℃ | 44 | 535535 | 234234 | 69.57%69.57% |
D+9D+9 | 19.9℃19.9℃ | 22 | 537537 | 232232 | 69.83%69.83% |
D+10D+10 | 19.9℃19.9℃ | 1One | 538538 | 231231 | 69.96%69.96% |
D+13D+13 | 19.9℃19.9℃ | 00 | 538538 | 231231 | 69.96%69.96% |
합계Sum | 538538 | 231231 | 69.96%69.96% |
생존 여부에 따른 GWAS 분석에서 확인된 주요 SNP 정보Key SNP information identified in GWAS analysis based on survival | |||||||||||
ChrChr | PosPos | IdId | A1A1 | A2A2 | freqA2freqA2 | tautau | betabeta | sdsd | pp | PVEPVE | Y (%)Y (%) |
1919 | 43443154344315 | AX-419312236AX-419312236 | GG | AA | 0.4860.486 | 1.1411.141 | -4.370-4.370 | 0.3380.338 | 3.49E-383.49E-38 | 0.1870.187 | 0.2500.250 |
1919 | 46873134687313 | AX-419197087AX-419197087 | AA | GG | 0.4630.463 | 1.7631.763 | 3.5353.535 | 0.2830.283 | 8.37E-368.37E-36 | 0.1770.177 | 0.2370.237 |
1919 | 43303724330372 | AX-419312234AX-419312234 | TT | CC | 0.4900.490 | 0.2210.221 | 4.6574.657 | 0.3740.374 | 1.52E-351.52E-35 | 0.1760.176 | 0.2350.235 |
1818 | 1263157812631578 | AX-419305596AX-419305596 | AA | GG | 0.4900.490 | 2.0082.008 | 3.6323.632 | 0.2920.292 | 1.69E-351.69E-35 | 0.1760.176 | 0.2350.235 |
1919 | 44611594461159 | AX-419194887AX-419194887 | TT | GG | 0.4590.459 | 1.5141.514 | -3.489-3.489 | 0.2890.289 | 1.22E-331.22E-33 | 0.1680.168 | 0.2240.224 |
1919 | 42483584248358 | AX-419194856AX-419194856 | CC | AA | 0.4800.480 | 1.5771.577 | 3.6103.610 | 0.3010.301 | 3.18E-333.18E-33 | 0.1660.166 | 0.2220.222 |
1919 | 27521902752190 | AX-419194727AX-419194727 | TT | GG | 0.3960.396 | 1.5831.583 | 2.0612.061 | 0.1770.177 | 1.76E-311.76E-31 | 0.1580.158 | 0.2120.212 |
1818 | 1254677812546778 | AX-419238898AX-419238898 | AA | GG | 0.4560.456 | 2.0302.030 | 3.2093.209 | 0.2780.278 | 8.13E-318.13E-31 | 0.1550.155 | 0.2080.208 |
1919 | 27936842793684 | AX-419311974AX-419311974 | TT | CC | 0.3220.322 | 2.1112.111 | -3.096-3.096 | 0.2830.283 | 7.29E-287.29E-28 | 0.1420.142 | 0.1900.190 |
1919 | 44097084409708 | AX-419310944AX-419310944 | GG | AA | 0.4610.461 | 2.2602.260 | -2.960-2.960 | 0.2710.271 | 9.63E-289.63E-28 | 0.1410.141 | 0.1890.189 |
1919 | 43523564352356 | AX-419312238AX-419312238 | TT | CC | 0.3120.312 | 2.1672.167 | 3.0693.069 | 0.2860.286 | 8.01E-278.01E-27 | 0.1370.137 | 0.1830.183 |
1919 | 51196035119603 | AX-419197131AX-419197131 | TT | CC | 0.4960.496 | 1.8741.874 | 2.4052.405 | 0.2260.226 | 2.20E-262.20E-26 | 0.1350.135 | 0.1800.180 |
1919 | 49958164995816 | AX-419311016AX-419311016 | AA | GG | 0.4550.455 | 2.1322.132 | 2.3722.372 | 0.2310.231 | 9.07E-259.07E-25 | 0.1270.127 | 0.1700.170 |
1919 | 44764164476416 | AX-419310954AX-419310954 | CC | TT | 0.4530.453 | 1.8501.850 | 2.2722.272 | 0.2260.226 | 8.43E-248.43E-24 | 0.1220.122 | 0.1640.164 |
1919 | 42304014230401 | AX-419194853AX-419194853 | AA | GG | 0.2670.267 | 3.8533.853 | -3.079-3.079 | 0.3100.310 | 3.48E-233.48E-23 | 0.1190.119 | 0.1600.160 |
1818 | 1282322412823224 | AX-419236852AX-419236852 | AA | CC | 0.3340.334 | 2.4532.453 | 2.8092.809 | 0.2840.284 | 5.04E-235.04E-23 | 0.1190.119 | 0.1590.159 |
1919 | 42613844261384 | AX-419194860AX-419194860 | AA | CC | 0.2880.288 | 2.1892.189 | 2.7162.716 | 0.2760.276 | 8.22E-238.22E-23 | 0.1180.118 | 0.1570.157 |
1919 | 41333624133362 | AX-419312202AX-419312202 | TT | CC | 0.3360.336 | 3.4893.489 | -3.063-3.063 | 0.3140.314 | 1.54E-221.54E-22 | 0.1160.116 | 0.1560.156 |
1919 | 47312944731294 | AX-419312293AX-419312293 | AA | CC | 0.4770.477 | 2.4442.444 | 2.3032.303 | 0.2370.237 | 2.46E-222.46E-22 | 0.1150.115 | 0.1540.154 |
1919 | 45930314593031 | AX-419197072AX-419197072 | GG | AA | 0.2750.275 | 3.9163.916 | -3.246-3.246 | 0.3340.334 | 2.82E-222.82E-22 | 0.1150.115 | 0.1540.154 |
1818 | 1157638211576382 | AX-419304244AX-419304244 | GG | TT | 0.4470.447 | 1.9311.931 | -2.241-2.241 | 0.2330.233 | 7.02E-227.02E-22 | 0.1130.113 | 0.1510.151 |
1919 | 28227052822705 | AX-419310690AX-419310690 | TT | CC | 0.2730.273 | 3.5123.512 | 2.8232.823 | 0.2950.295 | 9.97E-229.97E-22 | 0.1120.112 | 0.1500.150 |
1919 | 26944432694443 | AX-419194721AX-419194721 | CC | AA | 0.3110.311 | 3.2633.263 | -2.734-2.734 | 0.2880.288 | 2.47E-212.47E-21 | 0.1100.110 | 0.1480.148 |
1919 | 49973834997383 | AX-419194938AX-419194938 | AA | CC | 0.4170.417 | 2.9902.990 | 2.8892.889 | 0.3070.307 | 5.58E-215.58E-21 | 0.1090.109 | 0.1450.145 |
1919 | 43442794344279 | AX-419194866AX-419194866 | TT | CC | 0.3570.357 | 2.6342.634 | -2.457-2.457 | 0.2640.264 | 1.34E-201.34E-20 | 0.1070.107 | 0.1430.143 |
1919 | 44822724482272 | AX-419310955AX-419310955 | TT | CC | 0.2460.246 | 3.6353.635 | 2.8302.830 | 0.3050.305 | 1.47E-201.47E-20 | 0.1060.106 | 0.1420.142 |
1919 | 68011076801107 | AX-419311218AX-419311218 | TT | CC | 0.3710.371 | 1.4441.444 | 2.0512.051 | 0.2210.221 | 1.53E-201.53E-20 | 0.1060.106 | 0.1420.142 |
1818 | 1289038012890380 | AX-419238893AX-419238893 | CC | TT | 0.2600.260 | 3.5833.583 | 2.6502.650 | 0.2860.286 | 2.21E-202.21E-20 | 0.1060.106 | 0.1410.141 |
1818 | 1289095612890956 | AX-419305592AX-419305592 | AA | GG | 0.3490.349 | 3.6933.693 | -2.398-2.398 | 0.2610.261 | 4.09E-204.09E-20 | 0.1040.104 | 0.1390.139 |
1919 | 47819524781952 | AX-419194922AX-419194922 | TT | GG | 0.3010.301 | 2.1482.148 | 2.2722.272 | 0.2490.249 | 8.60E-208.60E-20 | 0.1030.103 | 0.1370.137 |
*Chr = 염색체, Pos = 염색체상의 SNP 위치, ID = SNP ID, A1 = 주요 대립유전자, A2 = 부 대립유전자, freqA2 = 부 대립유전자 빈도, beta = the SNP effect, sd = 표준에러, p = p-value, Y = SNP에 의한 표현형 값의 비율*Chr = chromosome, Pos = SNP location on chromosome, ID = SNP ID, A1 = major allele, A2 = minor allele, freqA2 = minor allele frequency, beta = the SNP effect, sd = standard error, p = p-value, Y = ratio of phenotypic values by SNP |
생존 일수에 따른 GWAS 분석에서 확인된 주요 SNP 정보Key SNP information identified in GWAS analysis by number of days to live | |||||||||||
ChrChr | PosPos | IDID | A1A1 | A2A2 | freqA2freqA2 | tautau | betabeta | sdsd | pp | PVEPVE | Y (%)Y (%) |
1919 | 43303724330372 | AX-419312234AX-419312234 | TT | CC | 0.4900.490 | 0.0390.039 | 3.1743.174 | 0.0940.094 | 1.96E-2471.96E-247 | 0.6090.609 | 0.7930.793 |
1919 | 43443154344315 | AX-419312236AX-419312236 | GG | AA | 0.4860.486 | 0.1680.168 | -3.164-3.164 | 0.1090.109 | 1.80E-1861.80E-186 | 0.5390.539 | 0.7020.702 |
1818 | 1263157812631578 | AX-419305596AX-419305596 | AA | GG | 0.4900.490 | 0.3560.356 | 2.9212.921 | 0.1270.127 | 1.01E-1161.01E-116 | 0.4210.421 | 0.5480.548 |
1919 | 46873134687313 | AX-419197087AX-419197087 | AA | GG | 0.4630.463 | 0.3140.314 | 3.1113.111 | 0.1370.137 | 1.75E-1131.75E-113 | 0.4140.414 | 0.5390.539 |
1919 | 42483584248358 | AX-419194856AX-419194856 | CC | AA | 0.4800.480 | 0.3320.332 | 2.9312.931 | 0.1300.130 | 4.23E-1124.23E-112 | 0.4110.411 | 0.5350.535 |
1919 | 44611594461159 | AX-419194887AX-419194887 | TT | GG | 0.4590.459 | 0.3770.377 | -3.081-3.081 | 0.1560.156 | 2.29E-862.29E-86 | 0.3480.348 | 0.4540.454 |
1818 | 1254677812546778 | AX-419238898AX-419238898 | AA | GG | 0.4560.456 | 0.4240.424 | 2.9712.971 | 0.1570.157 | 1.02E-791.02E-79 | 0.3300.330 | 0.4300.430 |
1919 | 27521902752190 | AX-419194727AX-419194727 | TT | GG | 0.3960.396 | 0.4740.474 | 2.0182.018 | 0.1160.116 | 1.03E-671.03E-67 | 0.2940.294 | 0.3830.383 |
1919 | 44097084409708 | AX-419310944AX-419310944 | GG | AA | 0.4610.461 | 0.5220.522 | -2.832-2.832 | 0.1740.174 | 2.84E-592.84E-59 | 0.2660.266 | 0.3470.347 |
1919 | 42304014230401 | AX-419194853AX-419194853 | AA | GG | 0.2670.267 | 0.6310.631 | -3.058-3.058 | 0.1900.190 | 3.46E-583.46E-58 | 0.2630.263 | 0.3420.342 |
1919 | 42941254294125 | AX-419194862AX-419194862 | GG | AA | 0.3240.324 | 0.6440.644 | -2.849-2.849 | 0.1780.178 | 1.64E-571.64E-57 | 0.2600.260 | 0.3390.339 |
1919 | 27936842793684 | AX-419311974AX-419311974 | TT | CC | 0.3220.322 | 0.4240.424 | -3.034-3.034 | 0.1940.194 | 3.99E-553.99E-55 | 0.2520.252 | 0.3280.328 |
1919 | 43523564352356 | AX-419312238AX-419312238 | TT | CC | 0.3120.312 | 0.4480.448 | 3.0363.036 | 0.1960.196 | 6.29E-546.29E-54 | 0.2480.248 | 0.3230.323 |
1919 | 41333624133362 | AX-419312202AX-419312202 | TT | CC | 0.3360.336 | 0.6100.610 | -3.098-3.098 | 0.2020.202 | 5.21E-535.21E-53 | 0.2440.244 | 0.3180.318 |
1919 | 45930314593031 | AX-419197072AX-419197072 | GG | AA | 0.2750.275 | 0.6170.617 | -3.117-3.117 | 0.2070.207 | 2.25E-512.25E-51 | 0.2380.238 | 0.3110.311 |
1919 | 28227052822705 | AX-419310690AX-419310690 | TT | CC | 0.2730.273 | 0.6240.624 | 2.9192.919 | 0.1990.199 | 1.01E-481.01E-48 | 0.2290.229 | 0.2980.298 |
1919 | 51196035119603 | AX-419197131AX-419197131 | TT | CC | 0.4960.496 | 0.5080.508 | 2.4522.452 | 0.1740.174 | 6.46E-456.46E-45 | 0.2140.214 | 0.2790.279 |
1919 | 26944432694443 | AX-419194721AX-419194721 | CC | AA | 0.3110.311 | 0.6100.610 | -2.671-2.671 | 0.1910.191 | 1.54E-441.54E-44 | 0.2130.213 | 0.2770.277 |
1919 | 44822724482272 | AX-419310955AX-419310955 | TT | CC | 0.2460.246 | 0.6550.655 | 3.1113.111 | 0.2260.226 | 2.71E-432.71E-43 | 0.2080.208 | 0.2710.271 |
1818 | 1289038012890380 | AX-419238893AX-419238893 | CC | TT | 0.2600.260 | 0.6430.643 | 2.8312.831 | 0.2060.206 | 5.05E-435.05E-43 | 0.2070.207 | 0.2690.269 |
1919 | 49973834997383 | AX-419194938AX-419194938 | AA | CC | 0.4170.417 | 0.5740.574 | 2.8492.849 | 0.2090.209 | 2.97E-422.97E-42 | 0.2040.204 | 0.2650.265 |
1919 | 49958164995816 | AX-419311016AX-419311016 | AA | GG | 0.4550.455 | 0.5590.559 | 2.4852.485 | 0.1840.184 | 9.48E-429.48E-42 | 0.2020.202 | 0.2630.263 |
1919 | 43013354301335 | AX-419310932AX-419310932 | GG | AA | 0.3510.351 | 0.6770.677 | -2.640-2.640 | 0.1960.196 | 1.90E-411.90E-41 | 0.2000.200 | 0.2610.261 |
1818 | 1282322412823224 | AX-419236852AX-419236852 | AA | CC | 0.3340.334 | 0.4900.490 | 2.8762.876 | 0.2130.213 | 2.28E-412.28E-41 | 0.2000.200 | 0.2610.261 |
1818 | 1289095612890956 | AX-419305592AX-419305592 | AA | GG | 0.3490.349 | 0.6550.655 | -2.484-2.484 | 0.1840.184 | 2.29E-412.29E-41 | 0.2000.200 | 0.2610.261 |
1919 | 44764164476416 | AX-419310954AX-419310954 | CC | TT | 0.4530.453 | 0.5640.564 | 2.3562.356 | 0.1780.178 | 3.62E-403.62E-40 | 0.1950.195 | 0.2540.254 |
1919 | 42613844261384 | AX-419194860AX-419194860 | AA | CC | 0.2880.288 | 0.5210.521 | 2.8612.861 | 0.2200.220 | 1.54E-381.54E-38 | 0.1880.188 | 0.2450.245 |
1919 | 47312944731294 | AX-419312293AX-419312293 | AA | CC | 0.4770.477 | 0.6010.601 | 2.4492.449 | 0.1910.191 | 1.29E-371.29E-37 | 0.1850.185 | 0.2400.240 |
1919 | 49994844999484 | AX-419312322AX-419312322 | GG | TT | 0.3410.341 | 0.6090.609 | 2.9132.913 | 0.2300.230 | 1.08E-361.08E-36 | 0.1810.181 | 0.2350.235 |
1919 | 47461514746151 | AX-419194919AX-419194919 | TT | CC | 0.3250.325 | 0.6580.658 | 2.4332.433 | 0.1990.199 | 1.80E-341.80E-34 | 0.1710.171 | 0.2230.223 |
*Chr = 염색체, Pos = 염색체상의 SNP 위치, ID = SNP ID, A1 = 주요 대립유전자, A2 = 부 대립유전자, freqA2 = 부 대립유전자 빈도, beta = the SNP effect, sd = 표준에러, p = p-value, Y = SNP에 의한 표현형 값의 비율*Chr = chromosome, Pos = SNP location on chromosome, ID = SNP ID, A1 = major allele, A2 = minor allele, freqA2 = minor allele frequency, beta = the SNP effect, sd = standard error, p = p-value, Y = ratio of phenotypic values by SNP |
생존 시간에 따른 GWAS 분석에서 확인된 주요 SNP 정보Key SNP information identified in GWAS analysis by survival time | |||||||||||
ChrChr | PosPos | IdId | A1A1 | A2A2 | freqA2freqA2 | tautau | betabeta | sdsd | pp | PVEPVE | Y (%)Y (%) |
1919 | 43303724330372 | AX-419312234AX-419312234 | TT | CC | 0.4900.490 | 0.0280.028 | 5.3505.350 | 0.1760.176 | 5.32E-2035.32E-203 | 0.5600.560 | 0.7220.722 |
1919 | 43443154344315 | AX-419312236AX-419312236 | GG | AA | 0.4860.486 | 0.1490.149 | -5.333-5.333 | 0.2010.201 | 2.35E-1552.35E-155 | 0.4930.493 | 0.6350.635 |
1919 | 46873134687313 | AX-419197087AX-419197087 | AA | GG | 0.4630.463 | 0.2760.276 | 5.2635.263 | 0.2470.247 | 1.50E-1001.50E-100 | 0.3840.384 | 0.4950.495 |
1818 | 1263157812631578 | AX-419305596AX-419305596 | AA | GG | 0.4900.490 | 0.3160.316 | 4.9134.913 | 0.2320.232 | 1.32E-991.32E-99 | 0.3820.382 | 0.4920.492 |
1919 | 42483584248358 | AX-419194856AX-419194856 | CC | AA | 0.4800.480 | 0.2950.295 | 4.9144.914 | 0.2380.238 | 7.26E-957.26E-95 | 0.3700.370 | 0.4770.477 |
1919 | 44611594461159 | AX-419194887AX-419194887 | TT | GG | 0.4590.459 | 0.3170.317 | -5.196-5.196 | 0.2790.279 | 1.37E-771.37E-77 | 0.3240.324 | 0.4170.417 |
1818 | 1254677812546778 | AX-419238898AX-419238898 | AA | GG | 0.4560.456 | 0.3760.376 | 5.0115.011 | 0.2810.281 | 6.50E-716.50E-71 | 0.3040.304 | 0.3920.392 |
1919 | 27521902752190 | AX-419194727AX-419194727 | TT | GG | 0.3960.396 | 0.4230.423 | 3.6213.621 | 0.2060.206 | 6.92E-696.92E-69 | 0.2980.298 | 0.3840.384 |
1919 | 44097084409708 | AX-419310944AX-419310944 | GG | AA | 0.4610.461 | 0.4660.466 | -4.747-4.747 | 0.3110.311 | 1.47E-521.47E-52 | 0.2430.243 | 0.3130.313 |
1919 | 27936842793684 | AX-419311974AX-419311974 | TT | CC | 0.3220.322 | 0.3750.375 | -5.181-5.181 | 0.3420.342 | 6.90E-526.90E-52 | 0.2400.240 | 0.3100.310 |
1919 | 42304014230401 | AX-419194853AX-419194853 | AA | GG | 0.2670.267 | 0.5900.590 | -5.130-5.130 | 0.3450.345 | 5.91E-505.91E-50 | 0.2330.233 | 0.3010.301 |
1919 | 42941254294125 | AX-419194862AX-419194862 | GG | AA | 0.3240.324 | 0.6000.600 | -4.788-4.788 | 0.3230.323 | 1.23E-491.23E-49 | 0.2320.232 | 0.2990.299 |
1919 | 43523564352356 | AX-419312238AX-419312238 | TT | CC | 0.3120.312 | 0.3960.396 | 5.0915.091 | 0.3470.347 | 1.11E-481.11E-48 | 0.2280.228 | 0.2950.295 |
1919 | 41333624133362 | AX-419312202AX-419312202 | TT | CC | 0.3360.336 | 0.5680.568 | -5.230-5.230 | 0.3660.366 | 2.72E-462.72E-46 | 0.2190.219 | 0.2830.283 |
1919 | 45930314593031 | AX-419197072AX-419197072 | GG | AA | 0.2750.275 | 0.5820.582 | -5.294-5.294 | 0.3740.374 | 1.75E-451.75E-45 | 0.2160.216 | 0.2790.279 |
1919 | 28227052822705 | AX-419310690AX-419310690 | TT | CC | 0.2730.273 | 0.5820.582 | 4.9864.986 | 0.3590.359 | 8.48E-448.48E-44 | 0.2100.210 | 0.2700.270 |
1919 | 51196035119603 | AX-419197131AX-419197131 | TT | CC | 0.4960.496 | 0.4520.452 | 4.1544.154 | 0.3080.308 | 1.89E-411.89E-41 | 0.2000.200 | 0.2580.258 |
1919 | 26944432694443 | AX-419194721AX-419194721 | CC | AA | 0.3110.311 | 0.5660.566 | -4.609-4.609 | 0.3430.343 | 3.57E-413.57E-41 | 0.1990.199 | 0.2570.257 |
1818 | 1289038012890380 | AX-419238893AX-419238893 | CC | TT | 0.2600.260 | 0.6000.600 | 4.8644.864 | 0.3710.371 | 2.95E-392.95E-39 | 0.1910.191 | 0.2470.247 |
1919 | 49958164995816 | AX-419311016AX-419311016 | AA | GG | 0.4550.455 | 0.5020.502 | 4.2254.225 | 0.3240.324 | 5.67E-395.67E-39 | 0.1900.190 | 0.2450.245 |
1818 | 1282322412823224 | AX-419236852AX-419236852 | AA | CC | 0.3340.334 | 0.4440.444 | 4.8784.878 | 0.3760.376 | 2.05E-382.05E-38 | 0.1880.188 | 0.2420.242 |
1919 | 49973834997383 | AX-419194938AX-419194938 | AA | CC | 0.4170.417 | 0.5350.535 | 4.8604.860 | 0.3760.376 | 2.75E-382.75E-38 | 0.1870.187 | 0.2420.242 |
1919 | 44822724482272 | AX-419310955AX-419310955 | TT | CC | 0.2460.246 | 0.6110.611 | 5.2415.241 | 0.4060.406 | 4.46E-384.46E-38 | 0.1860.186 | 0.2400.240 |
1818 | 1289095612890956 | AX-419305592AX-419305592 | AA | GG | 0.3490.349 | 0.6120.612 | -4.220-4.220 | 0.3320.332 | 5.84E-375.84E-37 | 0.1820.182 | 0.2340.234 |
1919 | 44764164476416 | AX-419310954AX-419310954 | CC | TT | 0.4530.453 | 0.4930.493 | 3.9673.967 | 0.3140.314 | 1.27E-361.27E-36 | 0.1800.180 | 0.2330.233 |
1919 | 43013354301335 | AX-419310932AX-419310932 | GG | AA | 0.3510.351 | 0.6280.628 | -4.404-4.404 | 0.3530.353 | 9.36E-369.36E-36 | 0.1770.177 | 0.2280.228 |
1919 | 42613844261384 | AX-419194860AX-419194860 | AA | CC | 0.2880.288 | 0.4600.460 | 4.7974.797 | 0.3860.386 | 1.91E-351.91E-35 | 0.1750.175 | 0.2260.226 |
1919 | 47312944731294 | AX-419312293AX-419312293 | AA | CC | 0.4770.477 | 0.5450.545 | 4.1004.100 | 0.3390.339 | 1.02E-331.02E-33 | 0.1680.168 | 0.2160.216 |
1919 | 49994844999484 | AX-419312322AX-419312322 | GG | TT | 0.3410.341 | 0.5720.572 | 4.9814.981 | 0.4120.412 | 1.39E-331.39E-33 | 0.1670.167 | 0.2160.216 |
1919 | 47461514746151 | AX-419194919AX-419194919 | TT | CC | 0.3250.325 | 0.6180.618 | 4.1704.170 | 0.3560.356 | 1.12E-311.12E-31 | 0.1590.159 | 0.2050.205 |
*Chr = 염색체, Pos = 염색체상의 SNP 위치, ID = SNP ID, A1 = 주요 대립유전자, A2 = 부 대립유전자, freqA2 = 부 대립유전자 빈도, beta = the SNP effect, sd = 표준에러, p = p-value, Y = SNP에 의한 표현형 값의 비율*Chr = chromosome, Pos = SNP location on chromosome, ID = SNP ID, A1 = major allele, A2 = minor allele, freqA2 = minor allele frequency, beta = the SNP effect, sd = standard error, p = p-value, Y = ratio of phenotypic values by SNP |
고수온 내성 개체 예측을 위한 SNP 및 이와 관련된 유전자 정보SNPs and genetic information related to them for prediction of high-temperature tolerance individuals | |||||||||
NoNo | ChrChr | PosPos | IdId | A1A1 | A2A2 | 염기서열base sequence |
고수온내성 유전자형high temperature resistance genotype |
관련 유전자related genes | RegionRegion |
1One | 1919 | 43443154344315 | AX-419312236AX-419312236 | GG | AA | GCAGGTTTATTTCTTTGCATATACACACAGTGACT[A/G]AGTTGAGCTCATCGTTAGCGAGGTGGCCTTACCAAGCAGGTTTATTTCTTTGCATATACACACAGTGACT[A/G]AGTTGAGCTCATCGTTAGCGAGGTGGCCTTACCAA | AA | (Upstream) myosin heavy chain, fast skeletal muscle-like(Downstream) NLR family CARD domain containing 5 (nlrc5)(Upstream) myosin heavy chain, fast skeletal muscle-like (Downstream) NLR family CARD domain containing 5 (nlrc5) | IntergenicIntergenic |
22 | 1919 | 46873134687313 | AX-419197087AX-419197087 | AA | GG | GGACGGCGCCTGCATGCGTATGGACGTGGAATCAG[A/G]ATCTGCCACCTCTGGTAAACAGTGTATTGTTTGTGGGACGGCGCCTGCATGCGTATGGACGTGGAATCAG[A/G]ATCTGCCACCTCTGGTAAACAGTGTATTGTTTGTG | AA | (Upstream) Unknown(Downstream) Unknown(Upstream) Unknown(Downstream) Unknown | IntergenicIntergenic |
33 | 1919 | 43303724330372 | AX-419312234AX-419312234 | TT | CC | TTAGGGGTAATGTTTTCTTCAGACTCAACAAGTAA[C/T]GACTTCAAAACACATATACTTTATAATAAAACACTTTAGGGGTAATGTTTTCTTCAGACTCAACAAGTAA[C/T]GACTTCAAAACACATATACTTTATAATAAAACACT | TT | (Upstream) myosin heavy chain, fast skeletal muscle-like(Downstream) myosin heavy chain, fast skeletal muscle-like(Upstream) myosin heavy chain, fast skeletal muscle-like (Downstream) myosin heavy chain, fast skeletal muscle-like | IntergenicIntergenic |
44 | 1818 | 1263157812631578 | AX-419305596AX-419305596 | AA | GG | AATTTAGAGTAAGCCCAGCACCCTCCTAACTCTTC[A/G]ATGACAAGACAACTTCTTTCACCTCCATACAGTAAAATTTAGAGTAAGCCCAGCACCCTCCTAACTCTTC[A/G]ATGACAAGACAACTTCTTTCACCTCCATACAGTAA | AA | (Upstream) glucose-fructose oxidoreductase domain-containing protein 1(Downstream) Unknown(Upstream) glucose-fructose oxidoreductase domain-containing protein 1 (Downstream) Unknown | IntergenicIntergenic |
55 | 1919 | 44611594461159 | AX-419194887AX-419194887 | TT | GG | TCAAGGTATTGTGTGTAAAACAGTTTGAGCAGTAT[G/T]AGGTCAGACTGCATGAGATCAGACTGCAGTAACTCTCAAGGTATTGTGTGTAAAACAGTTTGAGCAGTAT[G/T]AGGTCAGACTGCATGAGATCAGACTGCAGTAACTC | GG | (Upstream) Unknown(Downstream) Unknown(Upstream) Unknown(Downstream) Unknown | IntergenicIntergenic |
66 | 1919 | 42483584248358 | AX-419194856AX-419194856 | CC | AA | AATGCAAGATAATTGCATCCATTTAATTCATATCA[A/C]ATTCTTAACCACATCCTCTTCTCTGCTTCACCACAAATGCAAGATAATTGCATCCATTTAATTCATATCA[A/C]ATTCTTAACCACATCCTCTTCTTCTGCTTCACCACA | CC | HYDIN, axonemal central pair apparatus protein (hydin)HYDIN, axonemal central pair apparatus protein (hydin) | IntronIntron |
77 | 1919 | 27521902752190 | AX-419194727AX-419194727 | TT | GG | CACGCCACGATTTAATGGATGACTTGAAAATAATC[G/T]CTCATCAGGAAAGAAAGCCGGAGTCCAACTCAAGCCACGCCACGATTTAATGGATGACTTGAAAATAATC[G/T]CTCATCAGGAAAGAAAGCCGGAGTCCAACTCAAGC | TT | (Upstream) Unknown(Downstream) Unknown(Upstream) Unknown(Downstream) Unknown | IntergenicIntergenic |
88 | 1818 | 1254677812546778 | AX-419238898AX-419238898 | AA | GG | GTGTCGCCCCAGATTAGACTCATATGATGAGGTGA[A/G]AGAAACTCCCACTGGATCTGGGAACTCTTTAACTTGTGTCGCCCCAGATTAGACTCATATGATGAGGTGA[A/G]AGAAACTCCCACTGGATCTGGGAACTCTTTAACTT | AA | Rho GTPase activating protein 12 (arhgap12)Rho GTPase activating protein 12 (arhgap12) | IntronIntron |
99 | 1919 | 27936842793684 | AX-419311974AX-419311974 | TT | CC | TTAACTTTCTGAAATCTCTGCAGATTTTGAACCAG[C/T]GTTCTTCACCACTATCTCAACCCACTAGTTCTTGGTTAACTTTCTGAAATCTCTGCAGATTTTGAACCAG[C/T]GTTCTTCACCACTATCTCAACCCACTAGTTCTTGG | CC | (Upstream) Unknown(Downstream) protein serine kinase H1 (pskh1)(Upstream) Unknown(Downstream) protein serine kinase H1 (pskh1) | IntergenicIntergenic |
1010 | 1919 | 44097084409708 | AX-419310944AX-419310944 | GG | AA | AGACCAAAATCAGTCAACTGTATATTCAATTCTGA[A/G]GTTTGGGACACAGACAGGATTGAAATGCAGTTTCTAGACCAAAATCAGTCAACTGTATATTCAATTCTGA[A/G]GTTTGGGACACAGACAGGATTGAAATGCAGTTTCT | AA | (Upstream) exosome component 6 (exosc6)(Downstream) alanine--tRNA ligase, cytoplasmic-like(Upstream) exosome component 6 (exosc6) (Downstream) alanine--tRNA ligase, cytoplasmic-like | IntergenicIntergenic |
1111 | 1919 | 43523564352356 | AX-419312238AX-419312238 | TT | CC | CTCACTTGACAGAGATTTGTTTGCACCTGTGTTGT[C/T]CGATCTTTGCTTGTCACCACAATGAATATGGACAGCTCACTTGACAGAGATTTGTTTGCACCTGTGTTGT[C/T]CGATCTTTGCTTGTCACCACAATGAATATGGACAG | TT | NLR family CARD domain containing 5 (nlrc5)NLR family CARD domain containing 5 (nlrc5) | IntronIntron |
1212 | 1919 | 51196035119603 | AX-419197131AX-419197131 | TT | CC | ATGGAAGAAGATTGCCATTGAGCCACAAACAGTAA[C/T]CTCTTGTTCTGTGAATACTGAAATGATCCATGTCCATGGAAGAAGATTGCCATTGAGCCACAAACAGTAA[C/T]CTCTTGTTCTGTGAATACTGAAATGATCCATGTCC | TT | (Upstream) guanine nucleotide-binding protein G(o) subunit alpha(Downstream) guanine nucleotide-binding protein G(o) subunit alpha(Upstream) guanine nucleotide-binding protein G(o) subunit alpha (Downstream) guanine nucleotide-binding protein G(o) subunit alpha | IntergenicIntergenic |
1313 | 1919 | 49958164995816 | AX-419311016AX-419311016 | AA | GG | CATCGATGGTGTTGTTCAAAGAGACGAGATGAGGG[A/G]CCACAGTTTGATGAATTGTATTACAGATGATGATGCATCGATGGTGTTGTTCAAAGAGACGAGATGAGGG[A/G]CCACAGTTTGATGAATTGTATTACAGATGATGATG | AA | (Upstream) SET domain containing 6 (setd6)(Downstream) Bardet-Biedl syndrome 2 (bbs2)(Upstream) SET domain containing 6 (setd6) (Downstream) Bardet-Biedl syndrome 2 (bbs2) | IntergenicIntergenic |
1414 | 1919 | 44764164476416 | AX-419310954AX-419310954 | CC | TT | GGTTAATACTCAGACACATTATAATCTGTGAAAAC[C/T]GTGTCAGCGTGTATTACCGCTGGTTTTCTGTTTGCGGTTAATACTCAGACACATTATAATCTGTGAAAAC[C/T]GTGTCAGCGTGTATTACCGCTGGTTTTCTGTTTGC | CC | splicing factor 3b subunit 3 (sf3b3),splicing factor 3b subunit 3 (sf3b3); | IntronIntron |
1515 | 1919 | 42304014230401 | AX-419194853AX-419194853 | AA | GG | ATCCATAGGGGATTTATTTATGAAAGGCAGATCTT[A/G]GGTTTATTCACTCGGGCCTCCAAAGCACTGTGTTAATCCATAGGGGATTTATTTATGAAAGGCAGATCTT[A/G]GGTTTATTCACTCGGGCCTCCAAAGCACTGTGTTA | GG | HYDIN, axonemal central pair apparatus protein (hydin)HYDIN, axonemal central pair apparatus protein (hydin) | IntronIntron |
1616 | 1818 | 1282322412823224 | AX-419236852AX-419236852 | AA | CC | TTCTTCAGAGAGAAATGATCAAACCAATGATTTAC[A/C]TTCTGAATTCTGTGTCCCCAGGTTTATGAAAGAGGTTCTTCAGAGAGAAATGATCAAACCAATGATTTAC[A/C]TTCTGAATTCTGTGTCCCCAGGTTTTATGAAAGAGG | AA | (Upstream) Unknown(Downstream) Unknown(Upstream) Unknown(Downstream) Unknown | IntergenicIntergenic |
1717 | 1919 | 42613844261384 | AX-419194860AX-419194860 | AA | CC | GTGAGAACTGTACTCTGCCGCGGCTTTAACCACAC[A/C]TGACAATTACGACACGTGTCTGCAGCACCTTTAATGTGAGAACTGTACTCTGCCGCGGCTTTAACCACAC[A/C]TGACAATTACGACACGTGTCTGCAGCACCTTTAAT | AA | (Upstream) purine nucleoside phosphorylase-like(Downstream) calretinin-like(Upstream) purine nucleoside phosphorylase-like (Downstream) calretinin-like | IntergenicIntergenic |
1818 | 1919 | 41333624133362 | AX-419312202AX-419312202 | TT | CC | GGATGGATGCGGAGGATGTGAATGGATGTAGGCGA[C/T]CTTCTCTCCACACAAACATCTCTACCACCGACTGTGGATGGATGCGGAGGATGTGAATGGATGTAGGCGA[C/T]CTTCTCTCCACACAAACATCTCTACCACCGACTGT | CC | (Upstream) N-terminal EF-hand calcium binding protein 2 (necab2)(Downstream) N-terminal EF-hand calcium binding protein 2 (necab2)(Upstream) N-terminal EF-hand calcium binding protein 2 (necab2) (Downstream) N-terminal EF-hand calcium binding protein 2 (necab2) | IntergenicIntergenic |
1919 | 1919 | 47312944731294 | AX-419312293AX-419312293 | AA | CC | AAGCTCATAAAAGTAAGAGCTGTTGTTTGCTCTGT[A/C]AAATCAACTTCAGTAAGAGCCTGATGCTGGAGAGAAAGCTCATAAAAGTAAGAGCTGTTGTTTGCTCTGT[A/C]AAATCAACTTCAGTAAGAGCCTGATGCTGGAGAGA | AA | UnknownUnknown | IntronIntron |
2020 | 1919 | 45930314593031 | AX-419197072AX-419197072 | GG | AA | GACATTACATTTTGCAAAGAGAGTGGATTGAGGAG[A/G]ATGACATATTTAGAAGAGCATCAGTCAAACCTCAAGACATTACATTTTGCAAAGAGAGTGGATTGAGGAG[A/G]ATGACATATTTAGAAGAGCATCAGTCAAACCTCAA | AA | (Upstream) E3 ubiquitin-protein ligase Siah1(Downstream) NEDD4-binding protein 1 (n4bp1)(Upstream) E3 ubiquitin-protein ligase Siah1 (Downstream) NEDD4-binding protein 1 (n4bp1) | IntergenicIntergenic |
2121 | 1818 | 1157638211576382 | AX-419304244AX-419304244 | GG | TT | TGAAGTCGAGACACTTCCTTAAACAAACTGCCCTC[G/T]GGGGTTTGTTTCGGTCATACAGGCAGTAAGTGAGTTGAAGTCGAGACACTTCCTTAAACAAACTGCCCTC[G/T]GGGGTTTGTTTCGGTCATACAGGCAGTAAGTGAGT | TT | (Upstream) par-3 family cell polarity regulator (pard3)(Downstream) Unknown(Upstream) par-3 family cell polarity regulator (pard3) (Downstream) Unknown | IntergenicIntergenic |
2222 | 1919 | 28227052822705 | AX-419310690AX-419310690 | TT | CC | AACCATCTTTACCGCTACTCCAAGGTTCTGGAGGC[C/T]CACCTGGGAGACCCTAAGCCCCGCCCACTACCAGCAACCATCTTTACCGCTACTCCAAGGTTCTGGAGGC[C/T]CACCTGGGAGACCCTAAGCCCCGCCCACTACCAGC | TT | membrane bound transcription factor peptidase, site 1 (mbtps1)membrane bound transcription factor peptidase, site 1 (mbtps1) | ExonExon |
2323 | 1919 | 26944432694443 | AX-419194721AX-419194721 | CC | AA | CTAGCACCTGCGATGCTAATCTCGAGTTGAGTGAC[A/C]AGGAGCCAACGCGTTGTCATCGAACCGTCGTGTAACTAGCACCTGCGATGCTAATCTCGAGTTGAGTGAC[A/C]AGGAGCCAACGCGTTGTCATCGAACCGTCGTGTAA | AA | (Upstream) RAN binding protein 10 (ranbp10)(Downstream) translin associated factor X interacting protein 1 (tsnaxip1)(Upstream) RAN binding protein 10 (ranbp10) (Downstream) translin associated factor X interacting protein 1 (tsnaxip1) | IntergenicIntergenic |
2424 | 1919 | 49973834997383 | AX-419194938AX-419194938 | AA | CC | AACTACAATCACACAACATTTGCTAACGATACAAA[A/C]ACTATAATTTATGATGTTATACTACACATCATACTAACTACAATCACACAACATTTGCTAACGATACAAA[A/C]ACTATAATTTATGATGTTATACTACACATCATACT | AA | Bardet-Biedl syndrome 2 (bbs2)Bardet-Biedl syndrome 2 (bbs2) | IntronIntron |
2525 | 1919 | 43442794344279 | AX-419194866AX-419194866 | TT | CC | TTTACAGGCTTCAGTAAGAATCATTGTCTGAGCCA[C/T]GCAGGTTTATTTCTTTGCATATACACACAGTGACTTTTACAGGCTTCAGTAAGAATCATTGTCTGAGCCA[C/T]GCAGGTTTATTTCTTTGCATATACACACAGTGACT | CC | (Upstream) myosin heavy chain, fast skeletal muscle-like(Downstream) NLR family CARD domain containing 5 (nlrc5)(Upstream) myosin heavy chain, fast skeletal muscle-like (Downstream) NLR family CARD domain containing 5 (nlrc5) | IntergenicIntergenic |
2626 | 1919 | 44822724482272 | AX-419310955AX-419310955 | TT | CC | AATCAGGGGATGAATTGTAGTAACACTCTGTAAAA[C/T]ATTCTCTTGCTCAGGTGCTGGCAATGTCCAGTCGCAATCAGGGGATGAATTGTAGTAACACTCTGTAAAA[C/T]ATTCTCTTGCTCAGGTGCTGCAATGTCCAGTCGC | TT | splicing factor 3b subunit 3 (sf3b3)splicing factor 3b subunit 3 (sf3b3) | IntronIntron |
2727 | 1919 | 68011076801107 | AX-419311218AX-419311218 | TT | CC | GGTTCACTCTGCTCTGTGCAGAAATAGTACACAAA[C/T]TCCCAAACAGACACTACTGTTCTGTATTTCCCAGTGGTTCACTCTGCTCTGTGCAGAAATAGTACACAAA[C/T]TCCCAAACAGACACTACTGTTCTGTATTTCCCAGT | TT | SLIT-ROBO Rho GTPase activating protein 1 (srgap1)SLIT-ROBO Rho GTPase activating protein 1 (srgap1) | IntronIntron |
2828 | 1818 | 1289038012890380 | AX-419238893AX-419238893 | CC | TT | TTGGGCCTCCAGCACCCTTCGGTACACAGCATATA[C/T]AGAGCATCACACTATGTGATATTGGTAACCATCATTTGGGCCTCCAGCACCCTTCGGTACACAGCATATA[C/T]AGAGCATCACACTATGTGATATTGGTAACCATCAT | CC | (Upstream) Unknown(Downstream) potassium voltage-gated channel subfamily H member 2-like(Upstream) Unknown(Downstream) potassium voltage-gated channel subfamily H member 2-like | IntergenicIntergenic |
2929 | 1818 | 1289095612890956 | AX-419305592AX-419305592 | AA | GG | GGCATTGCAGGGTGCAGCAGGTTCAGATGCTATGG[A/G]GACAGTACATAAGCAGATGTGTTGGCAGCAGAGCTGGCATTGCAGGGTGCAGCAGGTTCAGATGCTATGG[A/G]GACAGTACATAAGCAGATGTGTTGGCAGCAGAGCT | GG | (Upstream) Unknown(Downstream) potassium voltage-gated channel subfamily H member 2-like(Upstream) Unknown(Downstream) potassium voltage-gated channel subfamily H member 2-like | IntergenicIntergenic |
3030 | 1919 | 47819524781952 | AX-419194922AX-419194922 | TT | GG | TTTATAGCCTAAACTGCAGTATTGTGTAGTGATAA[G/T]TTAATGCCAAAGAAATCAATTTTGAAATTTTGAAGTTTATAGCCTAAACTGCAGTATTGTGTAGTGATAA[G/T]TTAATGCCAAAGAAATCAATTTTGAAATTTTGAAG | TT | (Upstream) cerebellin 1 precursor 1 (cbln1)(Downstream) transmembrane protein 189-like(Upstream) cerebellin 1 precursor 1 (cbln1) (Downstream) transmembrane protein 189-like | IntergenicIntergenic |
서열 번호order number |
염색체 번호chromosome number |
SNP 위치SNPs location |
SNP IDSNP ID |
고수온내성 관련 유전자형high temperature resistance related genotype |
항목item | 유전자형 -1Genotype -1 | 유전자형-2genotype-2 | 유전자형-3genotype-3 | |
1One | 1919 | 43443154344315 | AX-419312236AX-419312236 | AA | 변이 (개체수)Variation (Number of Populations) | AA (190)AA (190) | GA (365)GA (365) | GG (170)G. G. (170) | |
평균 ± 표준편차mean ± standard deviation | 생존 일수number of days to live | 7.49 ± 1.537.49 ± 1.53 | 3.26 ± 2.133.26 ± 2.13 | 1.47 ± 1.021.47 ± 1.02 | |||||
생존 시간survival time | 11.79 ± 3.0111.79 ± 3.01 | 3.96 ± 3.813.96 ± 3.81 | 1.66 ± 1.441.66 ± 1.44 | ||||||
22 | 1919 | 46873134687313 | AX-419197087AX-419197087 | AA | 변이 (개체수)Variation (Number of Populations) | AA (153)AA (153) | AG (358)AG (358) | GG (206)G. G. (206) | |
평균 ± 표준편차mean ± standard deviation | 생존 일수number of days to live | 7.44 ± 1.537.44 ± 1.53 | 3.66 ± 2.133.66 ± 2.13 | 1.92 ± 1.021.92 ± 1.02 | |||||
생존 시간survival time | 11.72 ± 3.1211.72 ± 3.12 | 4.71 ± 4.414.71 ± 4.41 | 2.28 ± 2.632.28 ± 2.63 | ||||||
33 | 1919 | 43303724330372 | AX-419312234AX-419312234 | TT | 변이 (개체수)Variation (Number of Populations) | CC (191)CC (191) | TC (359)T-C (359) | TT (176)TT (176) | |
평균 ± 표준편차mean ± standard deviation | 생존 일수number of days to live | 1.46 ± 0.981.46 ± 0.98 | 3.35 ± 2.113.35 ± 2.11 | 7.85 ± 0.747.85 ± 0.74 | |||||
생존 시간survival time | 1.64 ± 1.361.64 ± 1.36 | 4.07 ± 3.834.07 ± 3.83 | 12.47 ± 1.712.47 ± 1.7 | ||||||
44 | 1818 | 1263157812631578 | AX-419305596AX-419305596 | AA | 변이 (개체수)Variation (Number of Populations) | AA (172)AA (172) | AG (366)AG (366) | GG (187)G. G. (187) | |
평균 ± 표준편차mean ± standard deviation | 생존 일수number of days to live | 7.38 ± 1.767.38 ± 1.76 | 3.45 ± 2.233.45 ± 2.23 | 1.76 ± 1.661.76 ± 1.66 | |||||
생존 시간survival time | 11.63 ± 3.311.63 ± 3.3 | 4.28 ± 4.034.28 ± 4.03 | 2.14 ± 2.652.14 ± 2.65 | ||||||
55 | 1919 | 44611594461159 | AX-419194887AX-419194887 | GG | 변이 (개체수)Variation (Number of Populations) | GG (186)G. G. (186) | GT (413)GT (413) | TT (126)TT (126) | |
평균 ± 표준편차mean ± standard deviation | 생존 일수number of days to live | 6.89 ± 2.196.89 ± 2.19 | 3.38 ± 2.403.38 ± 2.40 | 1.41 ± 0.671.41 ± 0.67 | |||||
생존 시간survival time | 10.67 ± 4.1510.67 ± 4.15 | 4.31 ± 4.244.31 ± 4.24 | 1.52 ± 0.481.52 ± 0.48 | ||||||
66 | 1919 | 42483584248358 | AX-419194856AX-419194856 | CC | 변이 (개체수)Variation (Number of Populations) | AA (186)AA (186) | CA (381)CA (381) | CC (157)CC (157) | |
평균 ± 표준편차mean ± standard deviation | 생존 일수number of days to live | 1.59 ± 1.291.59 ± 1.29 | 3.70 ± 2.393.70 ± 2.39 | 7.36 ± 1.787.36 ± 1.78 | |||||
생존 시간survival time | 1.85 ± 1.971.85 ± 1.97 | 4.73 ± 4.364.73 ± 4.36 | 11.59 ± 3.3411.59 ± 3.34 | ||||||
77 | 1919 | 27521902752190 | AX-419194727AX-419194727 | TT | 변이 (개체수)Variation (Number of Populations) | GG (329)G. G. (329) | TG (207)TG (207) | TT (180)TT (180) | |
평균 ± 표준편차mean ± standard deviation | 생존 일수number of days to live | 2.60 ± 2.122.60 ± 2.12 | 3.29 ± 2.293.29 ± 2.29 | 7.23 ± 1.887.23 ± 1.88 | |||||
생존 시간survival time | 3.19 ± 3.563.19 ± 3.56 | 4.10 ± 4.044.10 ± 4.04 | 11.32 ± 3.5911.32 ± 3.59 | ||||||
88 | 1818 | 1254677812546778 | AX-419238898AX-419238898 | AA | 변이 (개체수)Variation (Number of Populations) | AA (149)AA (149) | AG (364)AG (364) | GG (213)G. G. (213) | |
평균 ± 표준편차mean ± standard deviation | 생존 일수number of days to live | 6.66 ± 2.406.66 ± 2.40 | 4.02 ± 2.644.02 ± 2.64 | 1.92 ± 1.571.92 ± 1.57 | |||||
생존 시간survival time | 10.27 ± 4.4810.27 ± 4.48 | 5.39 ± 4.785.39 ± 4.78 | 2.24 ± 2.482.24 ± 2.48 | ||||||
99 | 1919 | 27936842793684 | AX-419311974AX-419311974 | CC | 변이 (개체수)Variation (Number of Populations) | CC (293)CC (293) | TC (398)TC (398) | TT (35)TT (35) | |
평균 ± 표준편차mean ± standard deviation | 생존 일수number of days to live | 5.93 ± 2.665.93 ± 2.66 | 2.69 ± 2.122.69 ± 2.12 | 1.57 ± 1.241.57 ± 1.24 | |||||
생존 시간survival time | 8.87 ± 5.018.87 ± 5.01 | 3.28 ± 3.563.28 ± 3.56 | 1.78 ± 1.961.78 ± 1.96 | ||||||
1010 | 1919 | 44097084409708 | AX-419310944AX-419310944 | AA | 변이 (개체수)Variation (Number of Populations) | AA (190)AA (190) | GA (401)GA (401) | GG (134)G. G. (134) | |
평균 ± 표준편차mean ± standard deviation | 생존 일수number of days to live | 6.44 ± 2.556.44 ± 2.55 | 3.49 ± 2.433.49 ± 2.43 | 1.79 ± 1.691.79 ± 1.69 | |||||
생존 시간survival time | 9.90 ± 4.79.90 ± 4.7 | 4.48 ± 4.334.48 ± 4.33 | 2.18 ± 2.722.18 ± 2.72 | ||||||
1111 | 1919 | 43523564352356 | AX-419312238AX-419312238 | TT | 변이 (개체수)Variation (Number of Populations) | CC (322)CC (322) | TC (355)TC (355) | TT (49)TT (49) | |
평균 ± 표준편차mean ± standard deviation | 생존 일수number of days to live | 2.41 ± 2.042.41 ± 2.04 | 4.79 ± 2.784.79 ± 2.78 | 7.92 ± 0.577.92 ± 0.57 | |||||
생존 시간survival time | 2.93 ± 3.342.93 ± 3.34 | 6.78 ± 5.156.78 ± 5.15 | 12.62 ± 1.3212.62 ± 1.32 | ||||||
1212 | 1919 | 51196035119603 | AX-419197131AX-419197131 | TT | 변이 (개체수)Variation (Number of Populations) | CC (180)CC (180) | TC (371)TC (371) | TT (174)TT (174) | |
평균 ± 표준편차mean ± standard deviation | 생존 일수number of days to live | 2.14 ± 1.952.14 ± 1.95 | 3.50 ± 2.453.50 ± 2.45 | 6.78 ± 2.296.78 ± 2.29 | |||||
생존 시간survival time | 2.62 ± 3.152.62 ± 3.15 | 4.51 ± 4.364.51 ± 4.36 | 10.46 ± 4.3510.46 ± 4.35 | ||||||
1313 | 1919 | 49958164995816 | AX-419311016AX-419311016 | AA | 변이 (개체수)Variation (Number of Populations) | AA (150)AA (150) | AG (361)AG (361) | GG (215)G. G. (215) | |
평균 ± 표준편차mean ± standard deviation | 생존 일수number of days to live | 6.71 ± 2.366.71 ± 2.36 | 3.85 ± 2.633.85 ± 2.63 | 2.18 ± 1.842.18 ± 1.84 | |||||
생존 시간survival time | 10.38 ± 4.4210.38 ± 4.42 | 5.14 ± 4.725.14 ± 4.72 | 2.60 ± 2.982.60 ± 2.98 | ||||||
1414 | 1919 | 44764164476416 | AX-419310954AX-419310954 | CC | 변이 (개체수)Variation (Number of Populations) | CC (139)CC (139) | CT (376)CT (376) | TT (207)TT (207) | |
평균 ± 표준편차mean ± standard deviation | 생존 일수number of days to live | 6.61 ± 2.426.61 ± 2.42 | 4.03 ± 2.684.03 ± 2.68 | 2.05 ± 1.712.05 ± 1.71 | |||||
생존 시간survival time | 10.18 ± 4.5310.18 ± 4.53 | 5.44 ± 4.835.44 ± 4.83 | 2.44 ± 2.762.44 ± 2.76 | ||||||
1515 | 1919 | 42304014230401 | AX-419194853AX-419194853 | GG | 변이 (개체수)Variation (Number of Populations) | AA (27)AA (27) | AG (334)AG (334) | GG (365)G. G. (365) | |
평균 ± 표준편차mean ± standard deviation | 생존 일수number of days to live | 2.19 ± 2.502.19 ± 2.50 | 2.75 ± 2.202.75 ± 2.20 | 5.17 ± 2.875.17 ± 2.87 | |||||
생존 시간survival time | 3.03 ± 4.163.03 ± 4.16 | 3.41 ± 3.733.41 ± 3.73 | 7.53 ± 5.257.53 ± 5.25 | ||||||
1616 | 1818 | 1282322412823224 | AX-419236852AX-419236852 | GG | 변이 (개체수)Variation (Number of Populations) | AA (59)AA (59) | AC (366)AC (366) | CC (299)CC (299) | |
평균 ± 표준편차mean ± standard deviation | 생존 일수number of days to live | 1.50 ± 0.711.50 ± 0.71 | 6.63 ± 2.396.63 ± 2.39 | 4.71 ± 2.854.71 ± 2.85 | |||||
생존 시간survival time | 10.19 ± 4.5310.19 ± 4.53 | 6.70 ± 5.206.70 ± 5.20 | 3.05 ± 3.443.05 ± 3.44 | ||||||
1717 | 1919 | 42613844261384 | AX-419194860AX-419194860 | AA | 변이 (개체수)Variation (Number of Populations) | AA (30)AA (30) | AC (357)AC (357) | CC (337)CC (337) | |
평균 ± 표준편차mean ± standard deviation | 생존 일수number of days to live | 7.87 ± 0.737.87 ± 0.73 | 4.99 ± 2.804.99 ± 2.80 | 2.50 ± 2.112.50 ± 2.11 | |||||
생존 시간survival time | 12.5 ± 1.6812.5±1.68 | 7.16 ± 5.207.16 ± 5.20 | 3.07 ± 3.483.07 ± 3.48 | ||||||
1818 | 1919 | 41333624133362 | AX-419312202AX-419312202 | CC | 변이 (개체수)Variation (Number of Populations) | CC (277)CC (277) | TC (410)TC (410) | TT (39)TT (39) | |
평균 ± 표준편차mean ± standard deviation | 생존 일수number of days to live | 5.52 ± 2.775.52 ± 2.77 | 3.08 ± 2.473.08 ± 2.47 | 1.90 ± 1.571.90 ± 1.57 | |||||
생존 시간survival time | 8.10 ± 5.168.10 ± 5.16 | 4.00 ± 4.264.00 ± 4.26 | 2.18 ± 2.552.18 ± 2.55 | ||||||
1919 | 1919 | 47312944731294 | AX-419312293AX-419312293 | AA | 변이 (개체수)Variation (Number of Populations) | AA (165)AA (165) | AC (362)AC (362) | CC (198)CC (198) | |
평균 ± 표준편차mean ± standard deviation | 생존 일수number of days to live | 6.19 ± 2.706.19 ± 2.70 | 3.87 ± 2.603.87 ± 2.60 | 2.23 ± 2.022.23 ± 2.02 | |||||
생존 시간survival time | 9.46 ± 4.959.46 ± 4.95 | 5.13 ± 4.685.13 ± 4.68 | 2.76 ± 3.332.76 ± 3.33 | ||||||
2020 | 1919 | 45930314593031 | AX-419197072AX-419197072 | AA | 변이 (개체수)Variation (Number of Populations) | AA (365)AA (365) | GA (321)GA (321) | GG (39)G. G. (39) | |
평균 ± 표준편차mean ± standard deviation | 생존 일수number of days to live | 4.97 ± 2.884.97 ± 2.88 | 3.02 ± 2.463.02 ± 2.46 | 2.03 ± 1.772.03 ± 1.77 | |||||
생존 시간survival time | 7.18 ± 5.257.18 ± 5.25 | 3.91 ± 4.213.91 ± 4.21 | 2.37 ± 2.832.37 ± 2.83 | ||||||
2121 | 1818 | 1157638211576382 | AX-419304244AX-419304244 | TT | 변이 (개체수)Variation (Number of Populations) | GG (130)G. G. (130) | GT (389)GT (389) | TT (207)TT (207) | |
평균 ± 표준편차mean ± standard deviation | 생존 일수number of days to live | 1.77 ± 1.481.77 ± 1.48 | 3.59 ± 2.523.59 ± 2.52 | 5.98 ± 2.795.98 ± 2.79 | |||||
생존 시간survival time | 2.05 ± 2.252.05 ± 2.25 | 4.68 ± 4.494.68 ± 4.49 | 9.09 ± 5.069.09 ± 5.06 | ||||||
2222 | 1919 | 28227052822705 | AX-419310690AX-419310690 | TT | 변이 (개체수)Variation (Number of Populations) | CC (339)CC (339) | TC (378)TC (378) | TT (9)TT (9) | |
평균 ± 표준편차mean ± standard deviation | 생존 일수number of days to live | 2.53 ± 2.052.53 ± 2.05 | 5.11 ± 2.875.11 ± 2.87 | 8.00 ± 0.008.00 ± 0.00 | |||||
생존 시간survival time | 3.09 ± 3.443.09 ± 3.44 | 7.43 ± 5.257.43 ± 5.25 | 12.81 ± 0.0012.81±0.00 | ||||||
2323 | 1919 | 26944432694443 | AX-419194721AX-419194721 | AA | 변이 (개체수)Variation (Number of Populations) | AA (305)AA (305) | CA (387)CA (387) | CC (31)CC (31) | |
평균 ± 표준편차mean ± standard deviation | 생존 일수number of days to live | 6.33 ± 2.896.33 ± 2.89 | 5.53 ± 2.835.53 ± 2.83 | 2.82 ± 2.262.82 ± 2.26 | |||||
생존 시간survival time | 8.18 ± 5.208.18 ± 5.20 | 3.53 ± 3.843.53 ± 3.84 | 2.55 ± 2.792.55 ± 2.79 | ||||||
2424 | 1919 | 49973834997383 | AX-419194938AX-419194938 | AA | 변이 (개체수)Variation (Number of Populations) | AA (116)AA (116) | AC (373)AC (373) | CC (236)CC (236) | |
평균 ± 표준편차mean ± standard deviation | 생존 일수number of days to live | 6.08 ± 2.706.08 ± 2.70 | 4.23 ± 2.834.23 ± 2.83 | 2.45 ± 2.022.45 ± 2.02 | |||||
생존 시간survival time | 9.19 ± 5.029.19 ± 5.02 | 5.90 ± 5.085.90 ± 5.08 | 2.97 ± 3.312.97 ± 3.31 | ||||||
2525 | 1919 | 43442794344279 | AX-419194866AX-419194866 | CC | 변이 (개체수)Variation (Number of Populations) | CC (270)CC (270) | TC (392)TC (392) | TT (63)TT (63) | |
평균 ± 표준편차mean ± standard deviation | 생존 일수number of days to live | 5.77 ± 2.715.77 ± 2.71 | 2.87 ± 2.292.87 ± 2.29 | 2.78 ± 2.532.78 ± 2.53 | |||||
생존 시간survival time | 8.57 ± 5.088.57 ± 5.08 | 3.60 ± 3.93.60 ± 3.9 | 3.70 ± 4.273.70 ± 4.27 | ||||||
2626 | 1919 | 44822724482272 | AX-419310955AX-419310955 | TT | 변이 (개체수)Variation (Number of Populations) | CC (397)CC (397) | TC (300)TC (300) | TT (28)TT (28) | |
평균 ± 표준편차mean ± standard deviation | 생존 일수number of days to live | 2.70 ± 2.192.70 ± 2.19 | 5.34 ± 2.845.34 ± 2.84 | 6.54 ± 2.46.54 ± 2.4 | |||||
생존 시간survival time | 3.35 ± 3.693.35 ± 3.69 | 7.82 ± 5.247.82 ± 5.24 | 9.95 ± 4.629.95 ± 4.62 | ||||||
2727 | 1919 | 68011076801107 | AX-419311218AX-419311218 | TT | 변이 (개체수)Variation (Number of Populations) | CC (287)CC (287) | TC (340)TC (340) | TT (99)TT (99) | |
평균 ± 표준편차mean ± standard deviation | 생존 일수number of days to live | 2.45 ± 2.062.45 ± 2.06 | 4.45 ± 2.814.45 ± 2.81 | 6.56 ± 2.436.56 ± 2.43 | |||||
생존 시간survival time | 3.01 ± 3.423.01 ± 3.42 | 6.20 ± 5.116.20 ± 5.11 | 10.07 ± 4.5610.07 ± 4.56 | ||||||
2828 | 1818 | 1289038012890380 | AX-419238893AX-419238893 | CC | 변이 (개체수)Variation (Number of Populations) | CC (2)CC (2) | CT (373)CT (373) | TT (351)TT (351) | |
평균 ± 표준편차mean ± standard deviation | 생존 일수number of days to live | 5.00 ± 4.245.00 ± 4.24 | 5.14 ± 2.895.14 ± 2.89 | 2.66 ± 2.162.66 ± 2.16 | |||||
생존 시간survival time | 7.42 ± 7.627.42 ± 7.62 | 7.50 ± 5.277.50 ± 5.27 | 3.29 ± 3.643.29 ± 3.64 | ||||||
2929 | 1818 | 1289095612890956 | AX-419305592AX-419305592 | GG | 변이 (개체수)Variation (Number of Populations) | AA (63)AA (63) | AG (381)AG (381) | GG (282)G. G. (282) | |
평균 ± 표준편차mean ± standard deviation | 생존 일수number of days to live | 2.68 ± 2.302.68 ± 2.30 | 3.04 ± 2.453.04 ± 2.45 | 5.45 ± 2.815.45 ± 2.81 | |||||
생존 시간survival time | 3.43 ± 3.913.43 ± 3.91 | 3.92 ± 4.203.92 ± 4.20 | 8.02 ± 5.198.02 ± 5.19 | ||||||
3030 | 1919 | 47819524781952 | AX-419194922AX-419194922 | TT | 변이 (개체수)Variation (Number of Populations) | GG (334)G. G. (334) | TG (338)TG (338) | TT (48)TT (48) | |
평균 ± 표준편차mean ± standard deviation | 생존 일수number of days to live | 2.42 ± 2.032.42 ± 2.03 | 5.09 ± 2.805.09 ± 2.80 | 6.42 ± 2.536.42 ± 2.53 | |||||
생존 시간survival time | 2.94 ± 3.332.94 ± 3.33 | 7.34 ± 5.207.34 ± 5.20 | 9.80 ± 4.759.80 ± 4.75 |
고수온 내성 관련 유전력Heritability associated with high temperature tolerance | ||||
표현형 형질phenotypic trait |
유전력 Heritability (h 2)heritability Heritability ( h 2 ) |
P-valueP-value | Significant to selectionSignificant to select | 주요 관련 염색체major related chromosomes |
생존 여부SurvivalSurvival | 0.6200.620 | 8.47 x 10-7 8.47 x 10 -7 |
Significant |
18 and 1918 and 19 |
생존 일수DPC_DayDays to surviveDPC_Day | 0.7530.753 | 8.47 x 10-7 8.47 x 10 -7 |
Significant |
18 and 1918 and 19 |
생존 시간DPC_Timesurvival timeDPC_Time | 0.7100.710 | 8.47 x 10-7 8.47 x 10 -7 |
Significant |
18 and 1918 and 19 |
Claims (7)
- 서열번호: 1의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 G 또는 A이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드;A polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 1, wherein the 36th base is G or A, and a polynucleotide consisting of 10 to 100 consecutive bases including the 36th base, or a polynucleotide complementary thereto;서열번호: 2의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 A 또는 G이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드;A polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 2, wherein the 36th base is A or G, and a polynucleotide consisting of 10 to 100 consecutive bases including the 36th base, or a polynucleotide complementary thereto;서열번호: 3의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 T 또는 C이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드;A polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 3, wherein the 36th base is T or C, and a polynucleotide consisting of 10 to 100 consecutive bases including the 36th base, or a polynucleotide complementary thereto;서열번호: 4의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 A 또는 G이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드;A polynucleotide consisting of 10 to 100 consecutive bases in which the 36th base of the polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 4 is A or G, including the 36th base, or a polynucleotide complementary thereto;서열번호: 5의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 T 또는 G이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드;A polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 5, wherein the 36th base is T or G, and a polynucleotide consisting of 10 to 100 consecutive bases including the 36th base, or a polynucleotide complementary thereto;서열번호: 6의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 C 또는 A이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드;A polynucleotide consisting of 10 to 100 consecutive bases in which the 36th base of the polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 6 is C or A, or a polynucleotide complementary thereto;서열번호: 7의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 T 또는 G이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드;A polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 7, wherein the 36th base is T or G, and 10 to 100 consecutive bases including the 36th base, or a polynucleotide complementary thereto;서열번호: 8의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 A 또는 G이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드;a polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 8, wherein the 36th base is A or G, and a polynucleotide consisting of 10 to 100 consecutive bases including the 36th base, or a polynucleotide complementary thereto;서열번호: 9의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 T 또는 C이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드;A polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 9, wherein the 36th base is T or C, and a polynucleotide consisting of 10 to 100 consecutive bases including the 36th base, or a polynucleotide complementary thereto;서열번호: 10의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 G 또는 A이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드; A polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 10, wherein the 36th base of the polynucleotide is G or A, and is composed of 10 to 100 consecutive bases including the 36th base, or a polynucleotide complementary thereto;서열번호: 11의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 T 또는 C이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드;The 36th base of the polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 11 is T or C, and a polynucleotide consisting of 10 to 100 consecutive bases including the 36th base or a polynucleotide complementary thereto;서열번호: 12의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 T 또는 C이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드;A polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 12, wherein the 36th base is T or C, and a polynucleotide consisting of 10 to 100 consecutive bases including the 36th base, or a polynucleotide complementary thereto;서열번호: 13의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 A 또는 G이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드;A polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 13, wherein the 36th base is A or G, and a polynucleotide consisting of 10 to 100 consecutive bases including the 36th base, or a polynucleotide complementary thereto;서열번호: 14의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 C 또는 T이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드;A polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 14, wherein the 36th base is C or T, and a polynucleotide consisting of 10 to 100 consecutive bases including the 36th base, or a polynucleotide complementary thereto;서열번호: 15의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 A 또는 G이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드;A polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 15, wherein the 36th base is A or G, and a polynucleotide consisting of 10 to 100 consecutive bases including the 36th base, or a polynucleotide complementary thereto;서열번호: 16의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 A 또는 C이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드;A polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 16, wherein the 36th base is A or C, and a polynucleotide consisting of 10 to 100 consecutive bases including the 36th base, or a polynucleotide complementary thereto;서열번호: 17의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 A 또는 C이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드;A polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 17, wherein the 36th base is A or C, and a polynucleotide consisting of 10 to 100 consecutive bases including the 36th base, or a polynucleotide complementary thereto;서열번호: 18의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 T 또는 C이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드;A polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 18, wherein the 36th base is T or C, and a polynucleotide consisting of 10 to 100 consecutive bases including the 36th base, or a polynucleotide complementary thereto;서열번호: 19의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 A 또는 C이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드; A polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 19, wherein the 36th base is A or C, and a polynucleotide consisting of 10 to 100 consecutive bases including the 36th base, or a polynucleotide complementary thereto;서열번호: 20의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 G 또는 A이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드;A polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 20, wherein the 36th base is G or A, and a polynucleotide consisting of 10 to 100 consecutive bases including the 36th base, or a polynucleotide complementary thereto;서열번호: 21의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 G 또는 T이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드;A polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 21, wherein the 36th base is G or T, and a polynucleotide consisting of 10 to 100 consecutive bases including the 36th base, or a polynucleotide complementary thereto;서열번호: 22의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 T 또는 C이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드;A polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 22, wherein the 36th base is T or C, and a polynucleotide consisting of 10 to 100 consecutive bases including the 36th base, or a polynucleotide complementary thereto;서열번호: 23의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 C 또는 A이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드;A polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 23, wherein the 36th base is C or A, and a polynucleotide consisting of 10 to 100 consecutive bases including the 36th base, or a polynucleotide complementary thereto;서열번호: 24의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 A 또는 C이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드;A polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 24, wherein the 36th base is A or C, and a polynucleotide consisting of 10 to 100 consecutive bases including the 36th base, or a polynucleotide complementary thereto;서열번호: 25의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 T 또는 C이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드;A polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 25, wherein the 36th base is T or C, and a polynucleotide consisting of 10 to 100 consecutive bases including the 36th base, or a polynucleotide complementary thereto;서열번호: 26의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 T 또는 C이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드;A polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 26, wherein the 36th base is T or C, and a polynucleotide consisting of 10 to 100 consecutive bases including the 36th base, or a polynucleotide complementary thereto;서열번호: 27의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 T 또는 C이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드;A polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 27, wherein the 36th base is T or C, and a polynucleotide consisting of 10 to 100 consecutive bases including the 36th base, or a polynucleotide complementary thereto;서열번호: 28의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 C 또는 T이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드;A polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 28, wherein the 36th base is C or T, and a polynucleotide consisting of 10 to 100 consecutive bases including the 36th base, or a polynucleotide complementary thereto;서열번호: 29의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 A 또는 G이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드; 및A polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 29, wherein the 36th base is A or G, and a polynucleotide consisting of 10 to 100 consecutive bases including the 36th base, or a polynucleotide complementary thereto; and서열번호: 30의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 T 또는 G이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드;로 이루어진 그룹에서 선택되는 1종 이상을 포함하는, The 36th base of the polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 30 is T or G, and a polynucleotide consisting of 10 to 100 consecutive bases including the 36th base or a polynucleotide complementary thereto; a group consisting of Including one or more selected from,넙치의 고수온 내성 예측용 SNP(Single nucleotide polymorphism) 마커 조성물.SNP (Single nucleotide polymorphism) marker composition for predicting high temperature tolerance of halibut.
- 제 1항에 있어서,According to claim 1,상기 서열번호: 1의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 A인 경우; 상기 서열번호: 2의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 A 인 경우; 상기 서열번호: 3의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 T 인 경우; 상기 서열번호: 4의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 A 인 경우; 상기 서열번호: 5의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 G 인 경우; 상기 서열번호: 6의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 C 인 경우; 상기 서열번호: 7의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 T 인 경우; 상기 서열번호: 8의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 A 인 경우; 상기 서열번호: 9의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 C 인 경우; 상기 서열번호: 10의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 A 인 경우; 상기 서열번호: 11의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 T 인 경우; 상기 서열번호: 12의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 T 인 경우; 상기 서열번호: 13의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 A 인 경우; 상기 서열번호: 14의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 C 인 경우; 상기 서열번호: 15의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 G 인 경우; 상기 서열번호: 16의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 A 인 경우; 상기 서열번호: 17의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 A 인 경우; 상기 서열번호: 18의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 C 인 경우; 상기 서열번호: 19의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 A 인 경우; 상기 서열번호: 20의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 A 인 경우; 상기 서열번호: 21의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 T 인 경우; 상기 서열번호: 22의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 T 인 경우; 상기 서열번호: 23의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 A 인 경우; 상기 서열번호: 24의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 A 인 경우; 상기 서열번호: 25의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 C 인 경우; 상기 서열번호: 26의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 T 인 경우; 상기 서열번호: 27의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 T 인 경우; 상기 서열번호: 28의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 C 인 경우; 상기 서열번호: 29의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 G 인 경우; 또는 상기 서열번호: 30의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 T 인 경우, 고수온 내성 넙치인 것으로 예측하는 것인, When the 36th base of the polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 1 is A; When the 36th base of the polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 2 is A; When the 36th base of the polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 3 is T; When the 36th base of the polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 4 is A; When the 36th base of the polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 5 is G; When the 36th base of the polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 6 is C; When the 36th base of the polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 7 is T; When the 36th base of the polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 8 is A; When the 36th base of the polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 9 is C; When the 36th base of the polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 10 is A; When the 36th base of the polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 11 is T; When the 36th base of the polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 12 is T; When the 36th base of the polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 13 is A; When the 36th base of the polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 14 is C; When the 36th base of the polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 15 is G; When the 36th base of the polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 16 is A; When the 36th base of the polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 17 is A; When the 36th base of the polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 18 is C; When the 36th base of the polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 19 is A; When the 36th base of the polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 20 is A; When the 36th base of the polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 21 is T; When the 36th base of the polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 22 is T; When the 36th base of the polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 23 is A; When the 36th base of the polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 24 is A; When the 36th base of the polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 25 is C; When the 36th base of the polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 26 is T; When the 36th base of the polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 27 is T; When the 36th base of the polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 28 is C; When the 36th base of the polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 29 is G; Or, if the 36th base of the polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 30 is T, predicting that it is a high temperature resistant flounder,넙치의 고수온 내성 예측용 SNP 마커 조성물.SNP marker composition for predicting high-temperature tolerance of halibut.
- 넙치의 고수온 내성 예측용 SNP 마커를 검출 또는 증폭할 수 있는 제제를 포함하는, 넙치의 고수온 내성 예측용 조성물로서,A composition for predicting high temperature resistance of flounder, comprising an agent capable of detecting or amplifying a SNP marker for predicting high temperature resistance of flounder,상기 SNP 마커는,The SNP marker,서열번호: 1의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 G 또는 A이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드;A polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 1, wherein the 36th base is G or A, and a polynucleotide consisting of 10 to 100 consecutive bases including the 36th base, or a polynucleotide complementary thereto;서열번호: 2의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 A 또는 G이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드;A polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 2, wherein the 36th base is A or G, and a polynucleotide consisting of 10 to 100 consecutive bases including the 36th base, or a polynucleotide complementary thereto;서열번호: 3의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 T 또는 C이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드;A polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 3, wherein the 36th base is T or C, and a polynucleotide consisting of 10 to 100 consecutive bases including the 36th base, or a polynucleotide complementary thereto;서열번호: 4의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 A 또는 G이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드;A polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 4, wherein the 36th base is A or G, and a polynucleotide consisting of 10 to 100 consecutive bases including the 36th base, or a polynucleotide complementary thereto;서열번호: 5의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 T 또는 G이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드;A polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 5, wherein the 36th base is T or G, and a polynucleotide consisting of 10 to 100 consecutive bases including the 36th base, or a polynucleotide complementary thereto;서열번호: 6의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 C 또는 A이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드;A polynucleotide consisting of 10 to 100 consecutive bases in which the 36th base of the polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 6 is C or A, or a polynucleotide complementary thereto;서열번호: 7의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 T 또는 G이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드;A polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 7, wherein the 36th base is T or G, and 10 to 100 consecutive bases including the 36th base, or a polynucleotide complementary thereto;서열번호: 8의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 A 또는 G이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드;a polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 8, wherein the 36th base is A or G, and a polynucleotide consisting of 10 to 100 consecutive bases including the 36th base, or a polynucleotide complementary thereto;서열번호: 9의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 T 또는 C이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드;A polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 9, wherein the 36th base is T or C, and a polynucleotide consisting of 10 to 100 consecutive bases including the 36th base, or a polynucleotide complementary thereto;서열번호: 10의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 G 또는 A이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드; A polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 10, wherein the 36th base of the polynucleotide is G or A, and is composed of 10 to 100 consecutive bases including the 36th base, or a polynucleotide complementary thereto;서열번호: 11의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 T 또는 C이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드;The 36th base of the polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 11 is T or C, and a polynucleotide consisting of 10 to 100 consecutive bases including the 36th base or a polynucleotide complementary thereto;서열번호: 12의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 T 또는 C이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드;A polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 12, wherein the 36th base is T or C, and a polynucleotide consisting of 10 to 100 consecutive bases including the 36th base, or a polynucleotide complementary thereto;서열번호: 13의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 A 또는 G이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드;A polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 13, wherein the 36th base is A or G, and a polynucleotide consisting of 10 to 100 consecutive bases including the 36th base, or a polynucleotide complementary thereto;서열번호: 14의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 C 또는 T이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드;A polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 14, wherein the 36th base is C or T, and a polynucleotide consisting of 10 to 100 consecutive bases including the 36th base, or a polynucleotide complementary thereto;서열번호: 15의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 A 또는 G이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드;A polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 15, wherein the 36th base is A or G, and a polynucleotide consisting of 10 to 100 consecutive bases including the 36th base, or a polynucleotide complementary thereto;서열번호: 16의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 A 또는 C이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드;A polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 16, wherein the 36th base is A or C, and a polynucleotide consisting of 10 to 100 consecutive bases including the 36th base, or a polynucleotide complementary thereto;서열번호: 17의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 A 또는 C이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드;A polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 17, wherein the 36th base is A or C, and a polynucleotide consisting of 10 to 100 consecutive bases including the 36th base, or a polynucleotide complementary thereto;서열번호: 18의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 T 또는 C이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드;A polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 18, wherein the 36th base is T or C, and a polynucleotide consisting of 10 to 100 consecutive bases including the 36th base, or a polynucleotide complementary thereto;서열번호: 19의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 A 또는 C이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드; A polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 19, wherein the 36th base is A or C, and a polynucleotide consisting of 10 to 100 consecutive bases including the 36th base, or a polynucleotide complementary thereto;서열번호: 20의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 G 또는 A이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드;A polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 20, wherein the 36th base is G or A, and a polynucleotide consisting of 10 to 100 consecutive bases including the 36th base, or a polynucleotide complementary thereto;서열번호: 21의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 G 또는 T이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드;A polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 21, wherein the 36th base is G or T, and a polynucleotide consisting of 10 to 100 consecutive bases including the 36th base, or a polynucleotide complementary thereto;서열번호: 22의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 T 또는 C이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드;A polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 22, wherein the 36th base is T or C, and a polynucleotide consisting of 10 to 100 consecutive bases including the 36th base, or a polynucleotide complementary thereto;서열번호: 23의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 C 또는 A이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드;A polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 23, wherein the 36th base is C or A, and a polynucleotide consisting of 10 to 100 consecutive bases including the 36th base, or a polynucleotide complementary thereto;서열번호: 24의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 A 또는 C이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드;A polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 24, wherein the 36th base is A or C, and a polynucleotide consisting of 10 to 100 consecutive bases including the 36th base, or a polynucleotide complementary thereto;서열번호: 25의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 T 또는 C이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드;A polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 25, wherein the 36th base is T or C, and a polynucleotide consisting of 10 to 100 consecutive bases including the 36th base, or a polynucleotide complementary thereto;서열번호: 26의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 T 또는 C이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드;A polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 26, wherein the 36th base is T or C, and a polynucleotide consisting of 10 to 100 consecutive bases including the 36th base, or a polynucleotide complementary thereto;서열번호: 27의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 T 또는 C이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드;A polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 27, wherein the 36th base is T or C, and a polynucleotide consisting of 10 to 100 consecutive bases including the 36th base, or a polynucleotide complementary thereto;서열번호: 28의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 C 또는 T이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드;A polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 28, wherein the 36th base is C or T, and a polynucleotide consisting of 10 to 100 consecutive bases including the 36th base, or a polynucleotide complementary thereto;서열번호: 29의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 A 또는 G이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드; 및A polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 29, wherein the 36th base is A or G, and a polynucleotide consisting of 10 to 100 consecutive bases including the 36th base, or a polynucleotide complementary thereto; and서열번호: 30의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 T 또는 G이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드;로 이루어진 그룹에서 선택되는 1종 이상을 포함하는, The 36th base of the polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 30 is T or G, and a polynucleotide consisting of 10 to 100 consecutive bases including the 36th base or a polynucleotide complementary thereto; a group consisting of Including one or more selected from,넙치의 고수온 내성 예측용 조성물.A composition for predicting high-temperature tolerance of halibut.
- 제 3항에 있어서,According to claim 3,상기 제제는 상기 SNP 마커를 검출 또는 증폭할 수 있는 프라이머 또는 프로브인 것을 특징으로 하는, 넙치의 고수온 내성 예측용 조성물.The preparation is characterized in that the primer or probe capable of detecting or amplifying the SNP marker, a composition for predicting high temperature tolerance of halibut.
- 제 3항의 조성물을 포함하는, 넙치의 고수온 내성 예측용 키트.A kit for predicting high temperature tolerance of halibut, comprising the composition of claim 3.
- (a) 넙치로부터 분리된 시료의 DNA로부터 넙치의 고수온 내성 예측용 SNP 마커의 다형성 부위를 증폭하거나 검출하는 단계 및(a) amplifying or detecting a polymorphic site of a SNP marker for predicting high temperature resistance of flounder from DNA of a sample isolated from flounder and(b) 상기 (a) 단계에서 증폭 또는 검출된 다형성 부위의 염기를 결정하는 단계를 포함하며,(b) determining the base of the polymorphic site amplified or detected in step (a);상기 (a)단계의 상기 SNP 마커는,The SNP marker in step (a),서열번호: 1의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 G 또는 A이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드;A polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 1, wherein the 36th base is G or A, and a polynucleotide consisting of 10 to 100 consecutive bases including the 36th base, or a polynucleotide complementary thereto;서열번호: 2의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 A 또는 G이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드;A polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 2, wherein the 36th base is A or G, and a polynucleotide consisting of 10 to 100 consecutive bases including the 36th base, or a polynucleotide complementary thereto;서열번호: 3의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 T 또는 C이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드;A polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 3, wherein the 36th base is T or C, and a polynucleotide consisting of 10 to 100 consecutive bases including the 36th base, or a polynucleotide complementary thereto;서열번호: 4의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 A 또는 G이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드;A polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 4, wherein the 36th base is A or G, and a polynucleotide consisting of 10 to 100 consecutive bases including the 36th base, or a polynucleotide complementary thereto;서열번호: 5의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 T 또는 G이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드;A polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 5, wherein the 36th base is T or G, and a polynucleotide consisting of 10 to 100 consecutive bases including the 36th base, or a polynucleotide complementary thereto;서열번호: 6의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 C 또는 A이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드;A polynucleotide consisting of 10 to 100 consecutive bases in which the 36th base of the polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 6 is C or A, or a polynucleotide complementary thereto;서열번호: 7의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 T 또는 G이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드;A polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 7, wherein the 36th base is T or G, and 10 to 100 consecutive bases including the 36th base, or a polynucleotide complementary thereto;서열번호: 8의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 A 또는 G이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드;a polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 8, wherein the 36th base is A or G, and a polynucleotide consisting of 10 to 100 consecutive bases including the 36th base, or a polynucleotide complementary thereto;서열번호: 9의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 T 또는 C이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드;A polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 9, wherein the 36th base is T or C, and a polynucleotide consisting of 10 to 100 consecutive bases including the 36th base, or a polynucleotide complementary thereto;서열번호: 10의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 G 또는 A이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드; A polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 10, wherein the 36th base of the polynucleotide is G or A, and is composed of 10 to 100 consecutive bases including the 36th base, or a polynucleotide complementary thereto;서열번호: 11의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 T 또는 C이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드;The 36th base of the polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 11 is T or C, and a polynucleotide consisting of 10 to 100 consecutive bases including the 36th base or a polynucleotide complementary thereto;서열번호: 12의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 T 또는 C이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드;A polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 12, wherein the 36th base is T or C, and a polynucleotide consisting of 10 to 100 consecutive bases including the 36th base, or a polynucleotide complementary thereto;서열번호: 13의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 A 또는 G이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드;A polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 13, wherein the 36th base is A or G, and a polynucleotide consisting of 10 to 100 consecutive bases including the 36th base, or a polynucleotide complementary thereto;서열번호: 14의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 C 또는 T이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드;A polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 14, wherein the 36th base is C or T, and a polynucleotide consisting of 10 to 100 consecutive bases including the 36th base, or a polynucleotide complementary thereto;서열번호: 15의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 A 또는 G이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드;A polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 15, wherein the 36th base is A or G, and a polynucleotide consisting of 10 to 100 consecutive bases including the 36th base, or a polynucleotide complementary thereto;서열번호: 16의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 A 또는 C이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드;A polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 16, wherein the 36th base is A or C, and a polynucleotide consisting of 10 to 100 consecutive bases including the 36th base, or a polynucleotide complementary thereto;서열번호: 17의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 A 또는 C이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드;A polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 17, wherein the 36th base is A or C, and a polynucleotide consisting of 10 to 100 consecutive bases including the 36th base, or a polynucleotide complementary thereto;서열번호: 18의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 T 또는 C이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드;A polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 18, wherein the 36th base is T or C, and a polynucleotide consisting of 10 to 100 consecutive bases including the 36th base, or a polynucleotide complementary thereto;서열번호: 19의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 A 또는 C이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드; A polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 19, wherein the 36th base is A or C, and a polynucleotide consisting of 10 to 100 consecutive bases including the 36th base, or a polynucleotide complementary thereto;서열번호: 20의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 G 또는 A이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드;A polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 20, wherein the 36th base is G or A, and a polynucleotide consisting of 10 to 100 consecutive bases including the 36th base, or a polynucleotide complementary thereto;서열번호: 21의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 G 또는 T이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드;A polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 21, wherein the 36th base is G or T, and a polynucleotide consisting of 10 to 100 consecutive bases including the 36th base, or a polynucleotide complementary thereto;서열번호: 22의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 T 또는 C이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드;A polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 22, wherein the 36th base is T or C, and a polynucleotide consisting of 10 to 100 consecutive bases including the 36th base, or a polynucleotide complementary thereto;서열번호: 23의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 C 또는 A이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드;A polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 23, wherein the 36th base is C or A, and a polynucleotide consisting of 10 to 100 consecutive bases including the 36th base, or a polynucleotide complementary thereto;서열번호: 24의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 A 또는 C이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드;A polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 24, wherein the 36th base is A or C, and a polynucleotide consisting of 10 to 100 consecutive bases including the 36th base, or a polynucleotide complementary thereto;서열번호: 25의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 T 또는 C이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드;A polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 25, wherein the 36th base is T or C, and a polynucleotide consisting of 10 to 100 consecutive bases including the 36th base, or a polynucleotide complementary thereto;서열번호: 26의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 T 또는 C이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드;A polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 26, wherein the 36th base is T or C, and a polynucleotide consisting of 10 to 100 consecutive bases including the 36th base, or a polynucleotide complementary thereto;서열번호: 27의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 T 또는 C이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드;A polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 27, wherein the 36th base is T or C, and a polynucleotide consisting of 10 to 100 consecutive bases including the 36th base, or a polynucleotide complementary thereto;서열번호: 28의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 C 또는 T이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드;A polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 28, wherein the 36th base is C or T, and a polynucleotide consisting of 10 to 100 consecutive bases including the 36th base, or a polynucleotide complementary thereto;서열번호: 29의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 A 또는 G이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드; 및A polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 29, wherein the 36th base is A or G, and a polynucleotide consisting of 10 to 100 consecutive bases including the 36th base, or a polynucleotide complementary thereto; and서열번호: 30의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 T 또는 G이고, 상기 36번째 염기를 포함하는 10 내지 100개의 연속적인 염기로 구성된 폴리뉴클레오티드 또는 이에 상보적인 폴리뉴클레오티드;로 이루어진 그룹에서 선택되는 1종 이상을 포함하는, The 36th base of the polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 30 is T or G, and a polynucleotide consisting of 10 to 100 consecutive bases including the 36th base or a polynucleotide complementary thereto; a group consisting of Including one or more selected from,넙치의 고수온 내성 예측 방법.A method for predicting high-temperature tolerance of halibut.
- 제 6항에 있어서,According to claim 6,상기 서열번호: 1의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 A인 경우; 상기 서열번호: 2의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 A 인 경우; 상기 서열번호: 3의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 T 인 경우; 상기 서열번호: 4의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 A 인 경우; 상기 서열번호: 5의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 G 인 경우; 상기 서열번호: 6의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 C 인 경우; 상기 서열번호: 7의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 T 인 경우; 상기 서열번호: 8의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 A 인 경우; 상기 서열번호: 9의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 C 인 경우; 상기 서열번호: 10의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 A 인 경우; 상기 서열번호: 11의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 T 인 경우; 상기 서열번호: 12의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 T 인 경우; 상기 서열번호: 13의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 A 인 경우; 상기 서열번호: 14의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 C 인 경우; 상기 서열번호: 15의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 G 인 경우; 상기 서열번호: 16의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 A 인 경우; 상기 서열번호: 17의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 A 인 경우; 상기 서열번호: 18의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 C 인 경우; 상기 서열번호: 19의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 A 인 경우; 상기 서열번호: 20의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 A 인 경우; 상기 서열번호: 21의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 T 인 경우; 상기 서열번호: 22의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 T 인 경우; 상기 서열번호: 23의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 A 인 경우; 상기 서열번호: 24의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 A 인 경우; 상기 서열번호: 25의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 C 인 경우; 상기 서열번호: 26의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 T 인 경우; 상기 서열번호: 27의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 T 인 경우; 상기 서열번호: 28의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 C 인 경우; 상기 서열번호: 29의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 G 인 경우; 또는 상기 서열번호: 30의 염기서열로 구성되는 폴리뉴클레오티드의 36번째 염기가 T 인 경우, 고수온 내성 넙치인 것으로 예측하는 것인,When the 36th base of the polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 1 is A; When the 36th base of the polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 2 is A; When the 36th base of the polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 3 is T; When the 36th base of the polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 4 is A; When the 36th base of the polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 5 is G; When the 36th base of the polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 6 is C; When the 36th base of the polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 7 is T; When the 36th base of the polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 8 is A; When the 36th base of the polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 9 is C; When the 36th base of the polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 10 is A; When the 36th base of the polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 11 is T; When the 36th base of the polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 12 is T; When the 36th base of the polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 13 is A; When the 36th base of the polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 14 is C; When the 36th base of the polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 15 is G; When the 36th base of the polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 16 is A; When the 36th base of the polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 17 is A; When the 36th base of the polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 18 is C; When the 36th base of the polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 19 is A; When the 36th base of the polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 20 is A; When the 36th base of the polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 21 is T; When the 36th base of the polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 22 is T; When the 36th base of the polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 23 is A; When the 36th base of the polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 24 is A; When the 36th base of the polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 25 is C; When the 36th base of the polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 26 is T; When the 36th base of the polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 27 is T; When the 36th base of the polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 28 is C; When the 36th base of the polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 29 is G; Or, if the 36th base of the polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 30 is T, predicting that it is a high temperature resistant flounder,넙치의 고수온 내성 예측 방법.A method for predicting high-temperature tolerance of halibut.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2024513518A JP2024534203A (en) | 2021-09-01 | 2022-08-25 | SNP markers for predicting high water temperature tolerance in flounder and their uses |
CN202280060964.8A CN118139992A (en) | 2021-09-01 | 2022-08-25 | SNP marker for predicting high water temperature resistance of paralichthys olivaceus and application thereof |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210116084A KR102384512B1 (en) | 2021-09-01 | 2021-09-01 | SNP markers for predicting thermal tolerance of Paralichthys olivaceus and use thereof |
KR10-2021-0116084 | 2021-09-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2023033457A1 true WO2023033457A1 (en) | 2023-03-09 |
Family
ID=81187839
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2022/012747 WO2023033457A1 (en) | 2021-09-01 | 2022-08-25 | Snp marker for predicting high water temperature tolerance of flatfish, and use thereof |
Country Status (4)
Country | Link |
---|---|
JP (1) | JP2024534203A (en) |
KR (5) | KR102384512B1 (en) |
CN (1) | CN118139992A (en) |
WO (1) | WO2023033457A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102384512B1 (en) * | 2021-09-01 | 2022-04-12 | 제주대학교 산학협력단 | SNP markers for predicting thermal tolerance of Paralichthys olivaceus and use thereof |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104328116A (en) * | 2014-11-06 | 2015-02-04 | 中国海洋大学 | SNP (single-nucleotide polymorphism) locus related to heat resistance of Paralichthys olivaceus and application thereof |
CN105624318A (en) * | 2016-03-24 | 2016-06-01 | 中国水产科学研究院北戴河中心实验站 | SNP site related to growth trait of paralichthys olivaceus as well as screening method and application of SNP site |
CN105713974A (en) * | 2016-03-24 | 2016-06-29 | 中国水产科学研究院北戴河中心实验站 | SNP locus related to paralichthys olivaceus quantitative character and screening method and application thereof |
CN109897905A (en) * | 2019-04-26 | 2019-06-18 | 上海海洋大学 | A kind of and the associated SNP marker of lefteye flounder Malpigmentation and its application |
KR102384512B1 (en) * | 2021-09-01 | 2022-04-12 | 제주대학교 산학협력단 | SNP markers for predicting thermal tolerance of Paralichthys olivaceus and use thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102080120B1 (en) | 2019-11-15 | 2020-02-21 | 대한민국 | Biomarker composition for predicting thermal-tolerance phenotype of Abalone |
-
2021
- 2021-09-01 KR KR1020210116084A patent/KR102384512B1/en active IP Right Grant
- 2021-12-20 KR KR1020210182975A patent/KR102384516B1/en active IP Right Grant
- 2021-12-20 KR KR1020210182972A patent/KR102384513B1/en active IP Right Grant
- 2021-12-20 KR KR1020210182974A patent/KR102384515B1/en active IP Right Grant
- 2021-12-20 KR KR1020210182973A patent/KR102384514B1/en active IP Right Grant
-
2022
- 2022-08-25 CN CN202280060964.8A patent/CN118139992A/en active Pending
- 2022-08-25 WO PCT/KR2022/012747 patent/WO2023033457A1/en active Application Filing
- 2022-08-25 JP JP2024513518A patent/JP2024534203A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104328116A (en) * | 2014-11-06 | 2015-02-04 | 中国海洋大学 | SNP (single-nucleotide polymorphism) locus related to heat resistance of Paralichthys olivaceus and application thereof |
CN105624318A (en) * | 2016-03-24 | 2016-06-01 | 中国水产科学研究院北戴河中心实验站 | SNP site related to growth trait of paralichthys olivaceus as well as screening method and application of SNP site |
CN105713974A (en) * | 2016-03-24 | 2016-06-29 | 中国水产科学研究院北戴河中心实验站 | SNP locus related to paralichthys olivaceus quantitative character and screening method and application thereof |
CN109897905A (en) * | 2019-04-26 | 2019-06-18 | 上海海洋大学 | A kind of and the associated SNP marker of lefteye flounder Malpigmentation and its application |
KR102384512B1 (en) * | 2021-09-01 | 2022-04-12 | 제주대학교 산학협력단 | SNP markers for predicting thermal tolerance of Paralichthys olivaceus and use thereof |
Also Published As
Publication number | Publication date |
---|---|
KR102384512B9 (en) | 2022-09-30 |
KR102384515B1 (en) | 2022-04-12 |
KR102384513B1 (en) | 2022-04-12 |
KR102384512B1 (en) | 2022-04-12 |
CN118139992A (en) | 2024-06-04 |
JP2024534203A (en) | 2024-09-18 |
KR102384516B1 (en) | 2022-04-12 |
KR102384514B1 (en) | 2022-04-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1397512A2 (en) | Method for detecting diseases caused by chromosomal imbalances | |
WO2008003244A1 (en) | Methods for identification of alleles | |
WO2023033457A1 (en) | Snp marker for predicting high water temperature tolerance of flatfish, and use thereof | |
WO2005123951A2 (en) | Methods of human leukocyte antigen typing by neighboring single nucleotide polymorphism haplotypes | |
Leschziner et al. | Q8IYL2 is a candidate gene for the familial epilepsy syndrome of Partial Epilepsy with Pericentral Spikes (PEPS) | |
EP2123777B1 (en) | Analysis for the genetic disposition for hip dysplasia in Canidae | |
KR102185440B1 (en) | Composition for early predicting or diagnosing hypercholesterolemia in dog | |
US20210180128A1 (en) | Method to confirm variants in ngs panel testing by snp genotyping | |
KR101138862B1 (en) | A polynucleotide associated with a breast cancer comprising single nucleotide polymorphism, microarray and diagnostic kit comprising the same and method for diagnosing a breast cancer using the same | |
CN1771337B (en) | A plynucleotide associated with a colon cancer comprising single nucleotide polymorphism, microarray and diagnostic kit comprising the same and method for diagnosing a colon cancer using the polynucle | |
KR101985659B1 (en) | Method for identification of Baekwoo breed using single nucleotide polymorphism markers | |
KR102281658B1 (en) | SNP marker for predicting resistant to viral hemorrhagic septicemia virus of Paralichthys olivaceus and use thereof | |
KR102318448B1 (en) | SNP marker for predicting resistant to lymphocystis disease of Paralichthys olivaceus and use thereof | |
KR101174823B1 (en) | Single nucleotide polymorphism marker for personal identification and its use | |
KR101663171B1 (en) | Biomarkers indicative of Down Syndrom and Their uses | |
KR102182740B1 (en) | Composition for identifying a bovine backfat thickness comprising an agent capable of detecting or amplifying a haplotype | |
WO2011078495A2 (en) | Chemo-sensitive prediction method for snp | |
KR102669168B1 (en) | SNP marker set for dog identification and dog identification method using the same | |
KR102083675B1 (en) | Method for identification of Chikso breed using single nucleotide polymorphism markers | |
JP6245796B2 (en) | Markers, probes, primers and kits for predicting the risk of developing primary biliary cirrhosis and methods for predicting the risk of developing primary biliary cirrhosis | |
KR102511161B1 (en) | HLA-A genotype analysis method using Korean-specific SNPs and optimized pipeline | |
CN110551804B (en) | Detection method for chimeric rate of chimera based on donor and acceptor | |
KR101731618B1 (en) | Single nucleotide polymorphism marker composition for identification of paternity and its use | |
JP6892102B2 (en) | Method for determining bovine leukemia virus (BLV) provirus load and its use | |
CN117867133A (en) | Application of PDGFD gene upstream SNP marker in sheep variety tail type selection |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 22864960 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2024513518 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 202280060964.8 Country of ref document: CN |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 22864960 Country of ref document: EP Kind code of ref document: A1 |